INTEL CORP
SC 13D, 2000-01-11
SEMICONDUCTORS & RELATED DEVICES
Previous: IMAGE SYSTEMS CORPORATION, 10QSB, 2000-01-11
Next: FORT JAMES CORP, 5, 2000-01-11



               SECURITIES AND EXCHANGE COMMISSION
                     Washington, D.C. 20549

                          SCHEDULE 13D
                         (Rule 13d-101)

     INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
             TO RULE 13d-1(a) AND AMENDMENTS THERETO
                 FILED PURSUANT TO RULE 13d-2(1)
                          (Amendment)*

                           ESOFT, INC.
          --------------------------------------------
                        (Name of Issuer)

                          Common Stock
          --------------------------------------------
                 (Title of Class of Securities)

                            296904105
          --------------------------------------------
                         (CUSIP Number)

                        F. Thomas Dunlap
          Vice President, General Counsel and Secretary
                        Intel Corporation
                 2200 Mission College Boulevard
                      Santa Clara, CA 95052
                    Telephone: (408) 765-8080
          --------------------------------------------
          (Name, Address and Telephone Number of Person
        Authorized to Receive Notices and Communications)

                        November 12, 1999
          --------------------------------------------
     (Date of Event which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule
13G  to  report  the  acquisition which is the  subject  of  this
Schedule  13D  and is filing this schedule because of  Rule  13d-
1 (e), 13d-1 (f) or 13d-1 (g), check the following box [  ].

*The  remainder  of this cover page shall be  filled  out  for  a
reporting  person's initial filing on this form with  respect  to
the subject class of securities, and for any subsequent amendment
containing information which would alter the disclosures provided
in a prior cover page.

The  information  required in the remainder of  this  cover  page
shall  not be deemed to be "filed" for the purpose of Section  18
of  the  Securities Exchange Act of 1934 (the "Act") or otherwise
subject  to the liabilities of that section of the Act but  shall
be  subject to all other provisions of the Act (however, see  the
Notes).

                       Page 1 of 12 Pages

<PAGE>

CUSIP NO. 296904105       Schedule 13D         Page 2 of 12 Pages


1.   NAME OF REPORTING PERSON:                  INTEL CORPORATION
     S.S.  or  I.R.S.  IDENTIFICATION  NO.  OF         94-1672743
     ABOVE PERSON:

2.   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP**    (a)[ ]
                                                           (b)[ ]
3.   SEC USE ONLY

4.   SOURCE OF FUNDS:                                          WC

5    CHECK  BOX  IF  DISCLOSURE OF LEGAL PROCEEDINGS  IS      [ ]
     REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)

6.   CITIZENSHIP OR PLACE OF ORGANIZATION:               DELAWARE

                7.   SOLE VOTING POWER:                   666,666
  NUMBER OF
    SHARES      8.   SHARED VOTING POWER:                     N/A
 BENEFICIALLY
OWNED BY EACH   9.   SOLE DISPOSITIVE POWER:              666,666
  REPORTING
 PERSON WITH    10.  SHARED DISPOSITIVE POWER:                N/A

11.  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH
     REPORTING PERSON:                                    666,666

12.  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11)
     EXCLUDES CERTAIN SHARES**                                [ ]

13.  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW             6%
     (11):

14.  TYPE OF REPORTING PERSON:                                 CO

<PAGE>

CUSIP NO. 296904105       Schedule 13D         Page 3 of 12 Pages


ITEM 1.   Security and Issuer.

          (a)    Name of Principal Executive Offices of Issuer:

                 eSoft, Inc.
                 295 Interlocken Blvd., #500
                 Broomfield, Colorado 80021

          (b)    Title of Class of Equity Securities:

                 Common Stock

ITEM 2.   Identity and Background.

          (a)    Name of Person Filing:

                 Intel Corporation (the "Reporting Person")

          (b)    Address of Principal Business Office:

                 2200 Mission College Boulevard
                 Santa Clara, CA 95052-8119

          (c)    Principal Business:

                 Manufacturer   of   microcomputer   components,
                 modules and systems.

          (d)    Criminal Proceedings:

                 During   the  last  five  years,  neither   the
                 Reporting  Person nor any executive officer  or
                 director  of  the  Reporting  Person  has  been
                 convicted in any criminal proceeding.

          (e)    Civil Proceedings:

                 During   the  last  five  years,  neither   the
                 Reporting  Person nor any executive officer  or
                 director of the Reporting Person has been party
                 to  any  civil  proceeding  of  a  judicial  or
                 administrative  body of competent  jurisdiction
                 as  a  result of which such person  was  or  is
                 subject to any judgment, decree or final  order
                 enjoining  future violations of, or prohibiting
                 or  mandating activities subject to, Federal or
                 State  securities laws or finding any violation
                 with respect to such laws.

<PAGE>

CUSIP NO. 296904105       Schedule 13D         Page 4 of 12 Pages


          (f)    Place of Organization:

                 Delaware

          Attached  hereto as Appendix A is information required
          by  this Item 2 with respect to the executive officers
          and  directors  of  the Reporting  Person.   All  such
          individuals  are  U.S. citizens, except  as  otherwise
          indicated on Appendix A.

ITEM 3.   Source and Amount of Funds or Other Consideration.

          (a)    Source of Funds:

                 Funds  for  the  purchase  of  the  Shares  (as
                 defined  in  Item 4) will be derived  from  the
                 Reporting Person's working capital.

          (b)    Amount of Funds:

                 The Reporting Person paid Three Million Dollars
                 ($3,000,000) to acquire the Shares (as  defined
                 in Item 4).

ITEM 4.   Purpose of the Transaction.

          Pursuant  to  a  Stock  Purchase and  Investor  Rights
          Agreement,  dated  November  12,  1999,  between   the
          Reporting   Person  and  the  Issuer  (the   "Purchase
          Agreement"), the Reporting Person agreed  to  purchase
          from  Issuer  the number of shares of Issuer's  Common
          Stock  (the  "Shares") equal to Three Million  Dollars
          ($3,000,000)  divided  by a per share  purchase  price
          equal to the lower of (i) the average closing price of
          one  share of the Issuer's Common Stock on the  Nasdaq
          Small  Cap  Market during the 30 day period ending  on
          the   last   trading  day  that  is  2  trading   days
          immediately  prior to the closing of the  purchase  of
          the Shares, and (ii) the closing price of one share of
          the  Issuer's  Common Stock on the  Nasdaq  Small  Cap
          Market  on  the last trading day immediately preceding
          the  closing of the purchase of the Shares.  The final
          per share purchase price for the Shares was $4.50.

          The  Reporting  Person  will hold  the  Shares  as  an
          investment.   Depending  on  the  Reporting   Person's
          evaluation   of   market  conditions,  market   price,
          alternative investment opportunities, liquidity  needs
          and other factors, the Reporting Person will from time
          to time explore opportunities for liquidating all or a
          portion  of  the  Shares, through one  or  more  sales
          pursuant  to public or private offerings or otherwise.
          In  such event, the Reporting Person may determine  to
          retain some portion of the Shares as an investment.

          In  addition, the Reporting Person and the Issuer have
          entered   into  a  software  license  and  development
          agreement,  pursuant to which the Issuer will  provide
          certain Internet connectivity development services  to
          the Reporting Person.

<PAGE>

CUSIP NO. 296904105       Schedule 13D         Page 5 of 12 Pages


ITEM 5.   Interest in Securities of the Issuer.

          The  information  contained in Item 4 is  incorporated
          herein by this reference.

          (a)    Number of Shares             666,666
                 Beneficially Owned:

                 Right to Acquire:            0

                 Percent of Class:            6% (based on
                                              10,957,985 shares
                                              of Common Stock
                                              outstanding,
                                              determined from
                                              representations
                                              and warranties
                                              made by the Issuer
                                              to the Reporting
                                              Person in the
                                              Purchase
                                              Agreement).

          (b)    Sole Power to Vote, Direct
                 the Vote of, or Dispose of   666,666
                 Shares:

          (c)    Recent Transactions:         See Item 4.

          (d)    Rights with Respect to
                 Dividends or Sales           N/A
                 Proceeds:

          (e)    Date of Cessation of Five
                 Percent Beneficial           N/A
                 Ownership:

ITEM 6.   Contracts,     Arrangements,     Understandings     or
          Relationships  with  Respect  to  Securities  of   the
          Issuer.

          Pursuant to the Purchase Agreement (as defined in  Item
          4),   the   Reporting   Person   has,   under   certain
          circumstances,   various   rights   related   to:   (a)
          registration  of the Shares pursuant to certain  shelf,
          demand  and  piggyback registration rights  granted  to
          the   Reporting  Person;  (b)  notification  and  first
          negotiation  in  connection  with  certain   sales   of
          securities,  acquisitions,  asset  sales,   grants   of
          licenses  and other corporate events of the  Issuer  or
          any  of  its  significant  subsidiaries;  and  (c)  the
          participation in future issuances of securities by  the
          Issuer  and  the maintenance of the Reporting  Person's
          percentage ownership of the Issuer.

ITEM 7.   Material to be Filed as Exhibits.

          Exhibit 1   eSoft,  Inc.  Stock Purchase and  Investor
                      Rights Agreement, dated November 12, 1999.
<PAGE>

CUSIP NO. 296904105       Schedule 13D         Page 6 of 12 Pages



                            SIGNATURE

After  reasonable  inquiry and to the best of  my  knowledge  and
belief,  I  certify  that  the  information  set  forth  in  this
statement is true, complete and correct.

Dated as of January 10, 2000.

                                 INTEL CORPORATION


                                 By:  /s/F. Thomas Dunlap, Jr.
                                      -------------------------
                                      F. Thomas Dunlap, Jr.
                                      Vice President, General
                                      Counsel and Secretary



<PAGE>

CUSIP NO. 296904105       Schedule 13D         Page 7 of 12 Pages



                           APPENDIX A

                            DIRECTORS

The following is a list of all Directors of Intel Corporation and
certain  other  information with respect to each  Director.   All
Directors are United States citizens except as indicated below.

Name:             Craig R. Barrett

Business          2200 Mission College Boulevard, Santa Clara,
Address:          CA 95052

Principal         President and Chief Executive Officer
Occupation:

Name, principal   Intel Corporation, a manufacturer of
business and      microcomputer components, modules and systems.
address of        2200 Mission College Boulevard
corporation or    Santa Clara, CA 95052
other
organization in
which employment
is conducted:


Name:             John Browne

Business          BP Amoco p.l.c., Britannic House, 1 Finsbury
Address:          Circus, London EC2M 7BA

Principal         Group Chief Executive
Occupation:

Name, principal   The BP Amoco p.l.c., an integrated oil
business and      company.
address of        Britannic House, 1 Finsbury Circus
corporation or    London EC2M 7BA
other
organization in
which employment
is conducted:

Citizenship:      British


<PAGE>

CUSIP NO. 296904105       Schedule 13D         Page 8 of 12 Pages


Name:             Winston H. Chen

Business          Paramitas Foundation, 3945 Freedom Circle,
Address:          Suite 760, Santa Clara, CA 95054

Principal         Chairman
Occupation:

Name, principal   Paramitas Foundation, a charitable foundation.
business and      3945 Freedom Circle, Suite 760
address of        Santa Clara, CA 95054
corporation or
other
organization in
which employment
is conducted:


Name:             Andrew S. Grove

Business          2200 Mission College Boulevard, Santa Clara,
Address:          CA 95052

Principal         Chairman of the Board of Directors
Occupation:

Name, principal   Intel Corporation, a manufacturer of
business and      microcomputer components, modules and systems.
address of        2200 Mission College Boulevard
corporation or    Santa Clara, CA 95052
other
organization in
which employment
is conducted:


Name:             D. James Guzy

Business          1340 Arbor Road, Menlo Park, CA 94025
Address:

Principal         Chairman
Occupation:

Name, principal   The Arbor Company, a limited partnership
business and      engaged in the electronics and computer
address of        industry.
corporation or    1340 Arbor Road
other             Menlo Park, CA 94025
organization in
which employment
is conducted:


<PAGE>

CUSIP NO. 296904105       Schedule 13D         Page 9 of 12 Pages


Name:             Gordon E. Moore

Business          2200 Mission College Boulevard, Santa Clara,
Address:          CA 95052

Principal         Chairman Emeritus of the Board of Directors
Occupation:

Name, principal   Intel Corporation, a manufacturer of
business and      microcomputer components, modules and systems.
address of        2200 Mission College Boulevard
corporation or    Santa Clara, CA 95052
other
organization in
which employment
is conducted:


Name:             David S. Pottruck

Business          101 Montgomery Street, San Francisco, CA 94104
Address:

Principal         President and Co-Chief Executive Officer
Occupation:

Name, principal   The Charles Schwab Corporation, an investment
business and      company
address of        101 Montgomery Street
corporation or    San Francisco, CA 94104
other
organization in
which employment
is conducted:


Name:             Jane E. Shaw

Business          1310 Orleans Drive, Sunnyvale, CA 94089
Address:

Principal         Chairman and Chief Executive Officer
Occupation:

Name, principal   AeroGen, Inc., a private company specializing
business and      in controlled delivery of drugs to the lungs
address of        1310 Orleans Drive
corporation or    Sunnyvale, CA 94089
other
organization in
which employment
is conducted:


<PAGE>

CUSIP NO. 296904105       Schedule 13D        Page 10 of 12 Pages


Name:             Leslie L. Vadasz

Business          2200 Mission College Boulevard, Santa Clara,
Address:          CA 95052

Principal         Senior Vice President, Director, Corporate
Occupation:       Business Development

Name, principal   Intel Corporation, a manufacturer of
business and      microcomputer components, modules and systems.
address of        2200 Mission College Boulevard
corporation or    Santa Clara, CA 95052
other
organization in
which employment
is conducted:


Name:             David B. Yoffie

Business          Harvard Business School, Morgan Hall 215,
Address:          Soldiers Field Road, Boston, MA 02163

Principal         Max and Doris Starr Professor of International
Occupation:       Business Administration

Name, principal   Harvard Business School, an educational
business and      institution.
address of        Harvard Business School
corporation or    Morgan Hall 215,Soldiers Field Road
other             Boston, MA 02163
organization in
which employment
is conducted:


Name:             Charles E. Young

Business          10920 Wilshire Boulevard, Suite 1835, Los
Address:          Angeles, CA 90024

Principal         A. Chancellor Emeritus
Occupation:
                  B. Interim President

Name, principal   A. University of California at Los Angeles, an
business and      educational institution.
address of             10920 Wilshire Boulevard, Suite 1835
corporation or          Los Angeles, CA 90024
other
organization in   B. University of Florida
which employment       226 Tigert Hall
is conducted:          PO Box 113150
                       Gainesville, FL 32610
<PAGE>

CUSIP NO. 296904105       Schedule 13D        Page 11 of 12 Pages


                       EXECUTIVE OFFICERS

The  following  is  a  list of all executive  officers  of  Intel
Corporation excluding executive officers who are also  directors.
Unless  otherwise indicated, each officer's business  address  is
2200  Mission  College Boulevard, Santa Clara, California  95052-
8119, which address is Intel Corporation's business address.

Name:       Paul S. Otellini
Title:      Executive  Vice  President,  General  Manager,  Intel
            Architecture Business Group

Name:       Gerhard H. Parker
Title:      Executive   Vice  President,  General  Manager,   New
            Business Group

Name:       Andy D. Bryant
Title:      Senior  Vice  President, Chief Financial Officer  and
            Enterprise Services Officer

Name:       Sean M. Maloney
Title:      Senior  Vice President, Director, Sales and Marketing
            Group

Name:       Michael R. Splinter
Title:      Senior  Vice  President, General Manager,  Technology
            and Manufacturing Group

Name:       Albert Y. C. Yu
Title:      Senior     Vice    President,    General     Manager,
            Microprocessor Products Group

Name:       F. Thomas Dunlap, Jr.
Title:      Vice President, General Counsel and Secretary

Name:       Arvind Sodhani
Title:      Vice President, Treasurer

<PAGE>

CUSIP NO. 296904105       Schedule 13D        Page 12 of 12 Pages



                          EXHIBIT INDEX

Exhibit No.    Document
- -----------    --------
Exhibit 1      eSoft,  Inc.  Stock Purchase and Investor  Rights
               Agreement, dated November 12, 1999.



<PAGE>
                            EXHIBIT 1


                 ESOFT, INC. STOCK PURCHASE AND
                    INVESTOR RIGHTS AGREEMENT

<PAGE>

                           ESOFT, INC.

          STOCK PURCHASE AND INVESTOR RIGHTS AGREEMENT

      This  Stock  Purchase and Investor Rights  Agreement  (this
"Agreement")  is made and entered into on November 12,  1999,  by
and  between eSoft, Inc., a Delaware corporation (the "Company"),
and Intel Corporation, a Delaware corporation (the "Investor").

                            RECITALS

      WHEREAS,  the Company desires to sell to the Investor,  and
the  Investor  desires to purchase from the  Company,  shares  of
Common  Stock,  par  value $.01 per share, of  the  Company  (the
"Common  Stock"), on the terms and conditions set forth  in  this
Agreement.

      NOW, THEREFORE, in consideration of the foregoing recitals,
the  mutual  promises hereinafter set forth, and other  good  and
valuable consideration, the receipt and sufficiency of which  are
hereby acknowledged, the parties hereto agree as follows:

1.   AGREEMENT TO PURCHASE AND SELL STOCK.

      (a)   Authorization.  The Company's Board of Directors (the
"Board")  will,  prior  to the Closing, authorize  the  issuance,
pursuant to the terms and conditions of this Agreement, of shares
of  Common  Stock in an amount equal to the number  of  Purchased
Shares (as defined in Section 1(b)).

     (b)  Agreement to Purchase and Sell Securities.  The Company
hereby agrees to issue to the Investor at the Closing (as defined
below),  and  the  Investor hereby agrees  to  acquire  from  the
Company  at  the  Closing, the number of shares of  Common  Stock
(collectively, the "Purchased Shares") equal to Two Million  Nine
Hundred  Ninety-Nine  Thousand Nine Hundred Ninety-Seven  Dollars
($2,999,997)  (the "Purchase Price") divided  by  the  Per  Share
Purchase  Price  (as defined below), rounded up  to  the  nearest
whole  share.   As  used in this Agreement, "Per  Share  Purchase
Price" equals $4.50.

      (c)  Use of Proceeds.  The Company intends to apply the net
proceeds  from  the  sale  of the Purchased  Shares  for  general
working capital purposes.

2.    CLOSING.   The  purchase and sale of the  Purchased  Shares
shall  take place at the offices of Gibson, Dunn & Crutcher  LLP,
1530  Page  Mill  Road,  Palo  Alto, California,  at  10:00  a.m.
California  time, on the date hereof (which time  and  place  are
referred to in this Agreement as the "Closing").  At the Closing,
the   Company   will   deliver  to  the   Investor   certificates
representing the Purchased Shares against delivery to the Company
by  the  Investor  of the Purchase Price in  cash  paid  by  wire
transfer of same-day funds to the Company.  Closing documents may
be  delivered by facsimile with original signature pages sent  by
overnight  courier.  The date of the this Agreement sometimes  is
referred to herein as the Closing Date.

<PAGE> 2

3.    REPRESENTATIONS AND WARRANTIES OF THE COMPANY.  The Company
hereby   represents  and  warrants  to  the  Investor  that   the
statements in this Section 3 are true and correct, except as  set
forth in the Disclosure Schedule (as defined in Section 7(a)):

      (a)   Organization,  Good Standing and Qualification.   The
Company is a corporation duly organized, validly existing and  in
good standing under the laws of the State of Delaware and has all
corporate  power and authority required to (a) own or  lease  its
properties  and  assets  and carry on its business  as  presently
conducted,  and  (b)  enter into this  Agreement  and  the  other
agreements, instruments and documents contemplated hereby, and to
consummate  the  transactions contemplated  hereby  and  thereby.
Each   of  the  Company's  subsidiaries  is  a  corporation  duly
organized, validly existing and in good standing under  the  laws
of  its jurisdiction of incorporation and has all corporate power
and  authority required to own or lease its properties and assets
and  carry on its business as presently conducted.  Each  of  the
Company and its subsidiaries is qualified to do business  and  is
in  good standing in each jurisdiction in which the failure to so
qualify  or be in good standing, either individually  or  in  the
aggregate,  would have a Material Adverse Effect on the  Company.
As  used  in  this Agreement, "Material Adverse Effect"  means  a
material adverse effect on, or a material adverse change in, or a
group of such effects on or changes in, the business, operations,
financial condition, results of operations, prospects, assets  or
liabilities  of the applicable party and its subsidiaries,  taken
as a whole.

      (b)   Capitalization.  The capitalization of  the  Company,
without  giving effect to the transactions contemplated  by  this
Agreement,  is as follows.  The authorized capital stock  of  the
Company  consists only of 50,000,000 shares of Common  Stock  and
5,000,000  shares of preferred stock, $.01 par value  ("Preferred
Stock"), of which 10,957,980 shares of Common Stock and no shares
of   Preferred   Stock  were  issued  and   outstanding   as   of
September  30, 1999.  All such shares of Common Stock  have  been
duly  authorized, and all such issued and outstanding  shares  of
Common  Stock  have  been  validly issued,  are  fully  paid  and
nonassessable  and  are free and clear of all liens,  claims  and
encumbrances,  other  than  any  liens,  claims  or  encumbrances
created  by  or  imposed  upon  the  holders  thereof.    As   of
September 30, 1999, the Company had also reserved:  (i) 3,013,071
shares  of Common Stock for issuance upon exercise of outstanding
options  granted  to officers, directors, employees,  independent
contractors  or  affiliates of the Company  or  its  subsidiaries
under the Company's equity incentive plans; (ii) 1,920,068 shares
of   Common   Stock  issuable  upon  exercise  of  the  Company's
outstanding warrants (the "Warrants"); and (iii) 1,277,955 shares
of  Common  Stock  issuable  upon  conversion  of  the  Company's
outstanding  Convertible  Debentures  due  June  10,  2002   (the
"Debentures").   As of September 30, 1999, (x) of  the  3,729,294
shares  of  Common Stock reserved for issuance upon  exercise  of
options, 3,013,071 shares remained subject to outstanding options
and  have  a  weighted  average exercise price  of  approximately
$2.45,  and  716,223 shares were reserved for future  grant;  and
(y)  of  the  1,920,068  and 1,277,955  shares  of  Common  Stock
initially  reserved for issuance upon exercise and conversion  of
the  Warrants and Debentures, respectively, none of  such  shares
has  been issued.  All shares of Common Stock subject to issuance
as aforesaid, upon issuance on the terms and conditions specified
in  the instruments pursuant to which they are issuable, will  be
duly  authorized,  validly issued, fully paid and  nonassessable.
There  are no other equity securities, options, warrants,  calls,
rights,  commitments or agreements of any character to which  the
Company is a party or by which it is bound obligating the Company
to

<PAGE> 3

issue,  deliver,  sell,  repurchase or redeem,  or  cause  to  be
issued,  delivered, sold, repurchased or redeemed, any shares  of
the  capital  stock of the Company or obligating the  Company  to
grant,  extend  or  enter into any such equity security,  option,
warrant, call, right, commitment or agreement.

      (c)   Due Authorization.  All corporate actions on the part
of   the   Company,  its  officers,  directors  and  stockholders
necessary for the authorization, execution, delivery of, and  the
performance  of  all  obligations  of  the  Company  under,  this
Agreement,  and  the  authorization,  issuance,  reservation  for
issuance  and delivery of all of the Purchased Shares being  sold
under  this  Agreement,  have  been  taken,  and  this  Agreement
constitutes  the  legal,  valid and  binding  obligation  of  the
Company,  enforceable against the Company in accordance with  its
terms, except (i) as may be limited by (A) applicable bankruptcy,
insolvency,  reorganization or others laws of general application
relating  to  or  affecting the enforcement of creditors'  rights
generally  and  (B)  the effect of rules  of  law  governing  the
availability  of  equitable  remedies  and  (ii)  as  rights   to
indemnity or contribution may be limited under federal  or  state
securities laws or by principles of public policy thereunder.

     (d)  Valid Issuance of Stock.

           (i)  Valid Issuance.  The shares of Common Stock to be
issued  pursuant to this Agreement are duly authorized and,  upon
payment of the Purchase Price by the Investor in accordance  with
this  Agreement,  will be validly issued,  fully  paid  and  non-
assessable.

           (ii)  Compliance with Securities Laws.   Assuming  the
correctness  of  the  representations made  by  the  Investor  in
Section 4, the Purchased Shares will be issued to the Investor in
compliance  with applicable exemptions from (A) the  registration
and  prospectus  delivery  requirements  of  the  Securities  Act
of   1933,  as  amended  (the  "Securities  Act"),  and  (B)  the
registration  and  qualification requirements of  all  applicable
securities laws of the states of the United States.

      (e)  Governmental Consents.  No consent, approval, order or
authorization  of,  or  registration qualification,  designation,
declaration or filing with, or notice to, any federal,  state  or
local governmental authority on the part of the Company or any of
its  subsidiaries is required in connection with the issuance  of
the  Purchased Shares to the Investor, or the consummation of the
other  transactions  contemplated by this Agreement,  except  for
(i)  the  listing  of the Purchased Shares on  Nasdaq,  (ii)  the
filing  of  a Form D with the Securities and Exchange  Commission
(the "SEC"), and (iii) the filing of a Notice of Transaction  and
a Form U-2 with the California Department of Corporations.

       (f)   Non-Contravention.   The  execution,  delivery   and
performance   of   this  Agreement  by  the  Company,   and   the
consummation  by  the  Company of the  transactions  contemplated
hereby  (including the issuance of the Purchased Shares), do  not
(i)  contravene  or  conflict with the Company's  Certificate  of
Incorporation or Bylaws, in each case as amended; (ii) constitute
a  violation  of  any provision of any federal, state,  local  or
foreign law binding upon or applicable to the Company or  any  of
its  subsidiaries; or (iii) constitute a default or  require  any
consent   under,   give  rise  to  any  right   of   termination,
cancellation or acceleration of, or to a loss of any  benefit  to
which  the Company or any of its subsidiaries is entitled  under,
or result in the

<PAGE> 4

creation or imposition of any lien, claim or encumbrance  on  any
assets  of  the  Company  or any of its subsidiaries  under,  any
contract  to which the Company or such subsidiary is a  party  or
any  permit, license or similar right relating to the Company  or
such subsidiary or by which the Company or such subsidiary may be
bound or affected.

      (g)   Litigation.   There is no action,  suit,  proceeding,
claim,  arbitration or investigation (each an  "Action")  pending
or,   to   the  best  of  the  Company's  knowledge,  threatened:
(i)  against the Company or any of its subsidiaries,  or  any  of
their  respective  activities, properties or assets,  or  any  of
their  respective officers, directors or employees of the Company
or  any  of  its subsidiaries in connection with such  officer's,
director's or employee's relationship with, or actions  taken  on
behalf of, the Company or such subsidiary, or (ii) that seeks  to
prevent, enjoin, alter or delay the transactions contemplated  by
this  Agreement (including the issuance of the Purchased Shares).
Neither the Company nor any of its subsidiaries is a party to  or
subject  to  the  provisions  of  any  order,  writ,  injunction,
judgment  or  decree  of  any  court  or  government  agency   or
instrumentality.   No  Action  by  the  Company  or  any  of  its
subsidiaries is currently pending nor does the Company or any  of
its subsidiaries intend to initiate any Action that is reasonably
likely to be material to the Company and its subsidiaries,  taken
as a whole.

     (h)  Compliance with Law and Charter Documents.  The Company
is  not  in  violation  or  default  of  any  provisions  of  its
Certificate of Incorporation or Bylaws, in each case as  amended.
The  Company  and  its  subsidiaries have  complied  and  are  in
compliance with all applicable statutes, laws, rules, regulations
and  orders  of  the  United States of  America  and  all  states
thereof,  foreign  countries and other  governmental  bodies  and
agencies having jurisdiction over their respective businesses  or
properties,  except  where  such  failure  to  comply  would  not
reasonably  be  likely to have a Material Adverse Effect  on  the
Company.

     (i)  SEC Documents.

           (i)   Reports.   The  Company  has  furnished  to  the
Investor prior to the date hereof copies of its Annual Report  on
Form  10-KSB/A-1  for  the fiscal year ended  December  31,  1998
("Form  10-K"),  its  Quarterly Reports on Form  10-QSB  for  the
fiscal quarters ended March 31, 1999 and June 30, 1999 (the "Form
10-Q's"),  and  all  other registration statements,  reports  and
proxy  statements filed by the Company with the SEC on  or  after
December  31,  1997  (the Form 10-K, the  Form  10-Q's  and  such
registration   statements,  reports  and  proxy  statements   are
collectively referred to herein as the "SEC Documents").   Except
to  the extent that information contained in any SEC Document has
been  revised  or  superseded by a later SEC Document  filed  and
publicly available prior to the date of this Agreement,  each  of
the  SEC  Documents,  as of the respective date  thereof  (or  if
amended or superseded by a filing prior to the Closing Date, then
on   the  date  of  such  filing),  did  not,  and  each  of  the
registration  statements, reports and proxy statements  filed  by
the  Company with the SEC after the date hereof and prior to  the
Closing  will  not,  as of the date thereof  (or  if  amended  or
superseded by a filing after the date of this Agreement, then  on
the  date  of  such filing), contain any untrue  statement  of  a
material fact or omit to state a material fact necessary in order
to   make   the  statements  made  therein,  in  light   of   the
circumstances  under  which  they  were  made,  not   misleading.
Neither the Company nor any of its subsidiaries is a party to any
material  contract,  agreement  or  other  arrangement  that  was
required  to  have been filed as an exhibit to the SEC  Documents
that was not so filed.

<PAGE> 5

           (ii)  Financial Statements.  The Company has  provided
the  Investor with copies of its audited financial statements for
the  fiscal  year  ended  December 31, 1998,  and  its  unaudited
financial statements for the six-month period ended June 30, 1999
(the  "Balance Sheet Date").  Since the Balance Sheet  Date,  the
Company  has duly filed with the SEC all registration statements,
reports and proxy statements required to be filed by it under the
Securities Exchange Act of 1934, as amended (the "Exchange Act"),
and  the  Securities Act.  The audited and unaudited consolidated
financial statements of the Company included in the SEC Documents
filed prior to the date hereof fairly present, in conformity with
generally accepted accounting principles ("GAAP") (except, in the
case  of  the Forms 10-QSB and 8-K, as may otherwise be permitted
by  Form  10-QSB  and  Forms 8-K) applied on a  consistent  basis
(except  as  otherwise may be stated in the notes  thereto),  the
consolidated  financial position of the Company as at  the  dates
thereof  and the consolidated results of its operations and  cash
flows  for  the  periods then ended (subject to  normal  year-end
audit  adjustments  in  the case of unaudited  interim  financial
statements).

      (j)   Absence of Certain Changes Since Balance Sheet  Date.
Since  the  Balance Sheet Date, the businesses and operations  of
the  Company  and  its subsidiaries have been  conducted  in  the
ordinary course consistent with past practice, and there has  not
been:

           (i)  any declaration, setting aside or payment of  any
dividend  or other distribution of the assets of the  Company  or
any  of  its  subsidiaries with respect to any shares of  capital
stock  of  the  Company or such subsidiary (except for  any  such
distribution by a wholly-owned subsidiary to the Company) or  any
repurchase, redemption or other acquisition by the Company or any
of  its  subsidiaries of any outstanding shares of the  Company's
capital stock;

           (ii)  any damage, destruction or loss, whether or  not
covered  by  insurance, except for such occurrences, individually
and  collectively, that are not material to the Company  and  its
subsidiaries, taken as a whole;

           (iii)      any  waiver by the Company or  any  of  its
subsidiaries  of a valuable right or of a material debt  owed  to
it,  except for such waivers, individually and collectively, that
are not material;

          (iv) any material change or amendment to, or any waiver
of any material right under a material contract or arrangement by
which  the  Company or any of its subsidiaries or  any  of  their
respective assets and properties is bound or subject, except  for
changes, amendments or waivers that are expressly provided for or
disclosed in this Agreement;

           (v)   any  change  by the Company  in  its  accounting
principles,  methods or practices or in the manner it  keeps  its
accounting books and records, except any such change required  by
a change in GAAP; or

           (vi)  any  other event or condition of any  character,
except for such events and conditions that have not resulted, and
could  not  reasonably be expected to result, either individually
or in the aggregate, in a Material Adverse Effect on the Company.

      (k)   Invention Assignment and Confidentiality  Agreements.
Each  employee  and consultant or independent contractor  of  the
Company or any of its subsidiaries whose duties

<PAGE> 6

include the development of products or Intellectual Property  (as
defined  below),  and  each  former employee  and  consultant  or
independent  contractor whose duties included the development  of
products  or Intellectual Property, has entered into and executed
an   invention   assignment  and  confidentiality  agreement   in
customary   form   or  an  employment  or  consulting   agreement
containing substantially similar terms.

     (l)  Intellectual Property.

           (i)   Ownership or Right to Use.  Each of the  Company
and  its  subsidiaries has sole title to and owns, or is licensed
or  otherwise possesses legally enforceable rights  to  use,  all
patents or patent applications, software, know-how, registered or
unregistered  trademarks and service marks and  any  applications
therefor, registered or unregistered copyrights, trade names, and
any applications therefor, trade secrets or other confidential or
proprietary  information (collectively, "Intellectual  Property")
necessary  to  enable  it to carry on its business  as  currently
conducted, except where any deficiency, or group of deficiencies,
would  not be reasonably likely to have a Material Adverse Effect
on the Company.

           (ii)  Licenses; Other Agreements.  Neither the Company
nor  any  of  its subsidiaries is currently the licensee  of  any
material portion of the Intellectual Property of the Company  and
its  subsidiaries.   There are not outstanding  any  licenses  or
agreements  of  any  kind relating to any  Intellectual  Property
owned  by  the  Company  or any of its subsidiaries,  except  for
agreements with customers entered into in the ordinary course  of
its   business   and   other  licenses   and   agreements   that,
collectively, are not material.  Neither the Company nor  any  of
its  subsidiaries  is  obligated to pay any  royalties  or  other
payments  to  third parties with respect to the marketing,  sale,
distribution,  manufacture, license or use  of  any  Intellectual
Property, except as the Company or any such subsidiary may be  so
obligated in the ordinary course of its business, as disclosed in
the Company's SEC Documents or where the aggregate amount of such
payments could not reasonably be expected to be material.

          (iii)     No Infringement.  Neither the Company nor any
of  its  subsidiaries has violated or infringed in  any  material
respect,  neither  the  Company nor any of  its  Subsidiaries  is
currently  violating or infringing in any material  respect,  and
neither the Company nor any of its subsidiaries has received  any
communications  alleging  that it (or any  of  its  employees  or
consultants) has violated or infringed, any Intellectual Property
of  any other person or entity, except for any such violations or
infringements  that  would not be reasonably  likely  to  have  a
Material Adverse Effect on the Company.

           (iv)  Employees and Consultants.  To the best  of  the
Company's knowledge, no employee of or consultant to the  Company
or  any of its subsidiaries is in material default under any term
of  any  material employment contract, agreement  or  arrangement
relating  to  Intellectual Property of the Company  or  any  such
subsidiary  or  any  material non-competition arrangement,  other
contract  or  restrictive covenant relating to  the  Intellectual
Property of the Company or any such subsidiary.  The Intellectual
Property  of  the Company or any of its subsidiaries (other  than
any  Intellectual Property duly acquired or licensed  from  third
parties)   was  developed  entirely  by  the  employees   of   or
consultants to the Company or one of its subsidiaries during  the
time  they  were  employed or retained by it,  and  to  the  best
knowledge  of  the  Company,  at no  time  during  conception  or
reduction to practice of such Intellectual Property

<PAGE> 7

of the Company or any of its subsidiaries were any such employees
or consultants operating under any grant from a government entity
or  agency  or  subject to any employment agreement or  invention
assignment  or  non-disclosure agreement or any other  obligation
with a third party that would materially and adversely affect the
Company's   or  such  subsidiary's  rights  in  its  Intellectual
Property.   Such Intellectual Property of the Company or  any  of
its  subsidiaries does not, to the best knowledge of the Company,
include  any  invention or other intellectual  property  of  such
employees or consultants made prior to the time such employees or
consultants were employed or retained by the Company or any  such
subsidiary nor any intellectual property of any previous employer
of such employees or consultants nor the intellectual property of
any other person or entity.

          (v)  Year 2000 Compliance.

                (a)   All  of the Company's and its subsidiaries'
material    products   (including   products   currently    under
development)  will  record,  store,  process  and  calculate  and
present  calendar dates falling on and after December  31,  1998,
and  will  calculate any information dependent on or relating  to
such  dates  in  the same manner and with the same functionality,
data  integrity  and performance as the products  record,  store,
process,  calculate  and  present calendar  dates  on  or  before
December 31, 1998, or calculate any information dependent  on  or
relating  to  such  dates (collectively, "Year 2000  Compliant").
All of the Company's and its subsidiaries' material products will
lose   no   significant  functionality  with   respect   to   the
introduction  of  records containing dates falling  on  or  after
December  31,  1998.  All of the Company's and its  subsidiaries'
internal   computer  systems  comprised  of  software,  hardware,
databases or embedded control systems (microprocessor controlled,
robotic  or  other  device)  related to  the  Company's  and  its
subsidiaries'  businesses (collectively,  a  "Business  System"),
that  constitutes any material part of, or is used in  connection
with the use, operation or enjoyment of, any material tangible or
intangible  asset  or  real  property  of  the  Company  and  its
subsidiaries,  including its accounting systems,  are  Year  2000
Compliant.   The  current  versions  of  the  Company's  and  its
subsidiaries' software and all other Intellectual Property may be
used prior to, during and after December 31, 1998, such that such
software and Intellectual Property will operate prior to,  during
and after such time period without error caused by date data that
represents  or  references different centuries or more  than  one
century.

                (b)  To the best knowledge of the Company, all of
the  Company's and its subsidiaries' products and the conduct  of
the Company's and its subsidiaries' businesses with customers and
suppliers will not be materially adversely affected by the advent
of  the year 2000, the advent of the twenty-first century or  the
transition from the twentieth century through the year  2000  and
into  the  twenty-first century.  To the best  knowledge  of  the
Company,  neither  the  Company nor any of  its  subsidiaries  is
reasonably  likely to incur expenses arising from or relating  to
the  failure  of  any  of its Business Systems  or  any  products
(including all products sold on or prior to the date hereof) as a
result  of  the  advent  of  the year 2000,  the  advent  of  the
twenty-first century or the transition from the twentieth century
through  the  year 2000, except for such expenses that  will  not
have a Material Adverse Effect on the Company.

      (m)  Subsidiaries.  Section 3(m) of the Disclosure Schedule
sets  forth all other persons, entities, or businesses  in  which
the  Company  presently owns or controls, directly or indirectly,
more than a 1% interest.

<PAGE> 8

      (n)   Environmental Matters.  During the  period  that  the
Company  or  any  of  its subsidiaries has owned  or  leased  its
properties  and  facilities, (i) there have  been  no  disposals,
releases  or threatened releases of Hazardous Materials on,  from
or under such properties or facilities which, either individually
or  in the aggregate, would have a Material Adverse Effect on the
Company,  and  (ii) neither the Company, any of its  subsidiaries
nor, to the Company's knowledge, any other person or entity,  has
used,  generated, manufactured or stored on, under or about  such
properties  or  facilities  or  transported  to  or   from   such
properties or facilities any Hazardous Materials, where such use,
generation, manufacture or storage, either individually or in the
aggregate,  would have a Material Adverse Effect on the  Company.
The Company has no knowledge of any presence, disposals, releases
or  threatened releases of Hazardous Materials on, from or  under
any  of  such  properties or facilities, which may have  occurred
prior  to  the  Company or any of its subsidiaries  having  taken
possession  of  any of such properties or facilities  and  which,
either  individually or in the aggregate, would have  a  Material
Adverse  Effect on the Company.  For purposes of this  Agreement,
the  terms "disposal," "release," and "threatened release"  shall
have  the  definitions  assigned  thereto  by  the  Comprehensive
Environmental Response, Compensation and Liability Act  of  1980,
42  U.S.C.  Section  9601  et seq., as amended  ("CERCLA").   For
purposes  of  this  Agreement, "Hazardous  Materials"  means  any
hazardous  or  toxic  substance,  material  or  waste  which   is
regulated   under,   or  defined  as  a  "hazardous   substance",
"pollutant",   "contaminant",   "toxic   chemical",    "hazardous
material",  "toxic  substance"  or  "hazardous  chemical"   under
(A)  CERCLA;  (B) the Emergency Planning and Community  Right-to-
Know  Act,  42  U.S.C. Section 11001 et seq.; (C)  the  Hazardous
Materials  Transportation Act, 49 U.S.C. Section 1801,  et  seq.;
(D)  the Toxic Substances Control Act, 15 U.S.C. Section 2601  et
seq.;  (E)  the  Occupational Safety  and  Health  Act  of  1970,
29  U.S.C. Section 651 et seq.; (F) regulations promulgated under
any  of the above statutes; or (G) any applicable state or  local
statute,  ordinance,  rule, or regulation that  has  a  scope  or
purpose similar to those statutes identified above.

      (o)   Registration Rights.  The Company  is  not  currently
subject to any agreement providing any person or entity with  any
rights  (including  piggyback registration rights)  to  have  any
securities  of the Company registered with the SEC or  registered
or qualified with any other governmental authority.

      (p)   Title  to  Property and Assets.  The  properties  and
assets of the Company or any of its subsidiaries are owned by the
Company or such subsidiary free and clear of all mortgages, deeds
of  trust,  liens,  charges, encumbrances and security  interests
except for statutory liens for the payment of current taxes  that
are  not  yet  delinquent  and liens, encumbrances  and  security
interests  that arise in the ordinary course of business  and  do
not  in any material respect affect the properties and assets  of
the Company or such subsidiary.  With respect to the property and
assets it leases, each of the Company and its subsidiaries is  in
compliance with such leases in all material respects.

      (q)  Tax Matters.  Each of the Company and its subsidiaries
has  filed  all material tax returns required to be filed,  which
returns  are true and correct in all material respects, and  each
of  the  Company and its subsidiaries has paid in full all  taxes
that  have  become due on or prior to the date hereof,  including
penalties  and  interest, assessments, fees  and  other  charges,
other  than  those being contested in good faith  and  for  which
adequate reserves have

<PAGE> 9

been  provided  or those currently payable without interest  that
were  payable  pursuant to said returns or any  assessments  with
respect thereto.

      (r)   Brokers  and  Finders.   None  of  the  Company,  its
subsidiaries,  their respective directors or officers  and  their
respective  agents  has  incurred any  obligation  or  liability,
contingent  or  otherwise,  for brokerage  or  finders'  fees  or
agents'  commissions or other similar payment in connection  with
this  Agreement  or any of the transactions contemplated  hereby.
The  Company  will indemnify and hold the Investor harmless  from
any  brokerage or finder's fees or agents' commissions  or  other
similar  payment alleged to be due by or through the  Company  or
any  of such other persons and entities as a result of the action
of  the Company, its subsidiaries, their respective directors  or
officers or their respective agents.

      (s)   Interested Party Transactions.  To the best knowledge
of  the Company, no officer or director of the Company or any  of
its  subsidiaries  or  any "affiliate" or "associate"  (as  those
terms  are  defined in Rule 405 promulgated under the  Securities
Act)  of  any  such person or entity has had, either directly  or
indirectly,  a  material interest in:  (i) any person  or  entity
which  purchases  from or sells, licenses  or  furnishes  to  the
Company   or  any  of  its  subsidiaries  any  goods,   property,
technology, intellectual or other property rights or services; or
(ii) any contract or agreement to which the Company or any of its
subsidiaries  is a party or by which it or any of its  properties
and assets may be bound or affected.

      (t)   Full Disclosure.  The information contained  in  this
Agreement,  the  Disclosure Schedule and the SEC  Documents  with
respect   to   the  business,  operations,  assets,  results   of
operations  and  financial  condition  of  the  Company  and  its
subsidiaries, and the transactions contemplated by this Agreement
,  are true and complete in all material respects and do not omit
to  state any material fact or facts necessary in order  to  make
the statements therein, in light of the circumstances under which
they were made, not misleading.

4.    REPRESENTATIONS, WARRANTIES AND CERTAIN AGREEMENTS  OF  THE
INVESTOR.   The  Investor hereby represents and warrants  to  the
Company, and agrees that:

      (a)   Organization,  Good Standing and Qualification.   The
Investor is a corporation duly organized, validly existing and in
good standing under the laws of the State of Delaware and has all
corporate  power  and  authority required to  own  or  lease  its
properties  and  assets  and carry on its business  as  presently
conducted.  The Investor is qualified to do business  and  is  in
good  standing  in each jurisdiction in which the failure  to  so
qualify  or be in good standing, either individually  or  in  the
aggregate, would have a Material Adverse Effect on the Investor.

     (b)  Due Authorization.  The execution of this Agreement has
been  duly  authorized by all necessary corporate action  on  the
part  of the Investor.  This Agreement constitutes the Investor's
legal,  valid  and  binding obligation, enforceable  against  the
Investor  in  accordance with its terms, except  (i)  as  may  be
limited  by (A) applicable bankruptcy, insolvency, reorganization
or other laws of general application relating to or affecting the
enforcement of creditors' rights generally and (B) the effect  of
rules of law governing the availability of

<PAGE> 10

equitable   remedies  and  (ii)  as  rights   to   indemnity   or
contribution  may  be limited under federal or  state  securities
laws or by principles of public policy hereunder.

      (c)  Governmental Consents.  No consent, approval, order or
authorization  of,  or registration, qualification,  designation,
declaration  or  filing  with,  any  federal,  state   or   local
governmental authority on the part of the Investor is required in
connection  with  the  purchase of the Purchased  Shares  by  the
Investor pursuant to this Agreement.

       (d)   Non-Contravention.   The  execution,  delivery   and
performance   of  this  Agreement  by  the  Investor,   and   the
consummation  by  the  Investor of the transactions  contemplated
hereby, do not (i) contravene or conflict with the Certificate of
Incorporation or Bylaws of the Investor, in each case as amended;
(ii)  constitute  a violation of any provision  of  any  federal,
state,  local  or foreign law binding upon or applicable  to  the
Investor;  or (iii) constitute a default or require  any  consent
under,  give  rise to any right of termination,  cancellation  or
acceleration  of,  or  to  a loss of any  benefit  to  which  the
Investor  is  entitled  under,  or  result  in  the  creation  or
imposition of any lien, claim or encumbrance on any assets of the
Investor under, any contract to which the Investor is a party  or
any permit, license or similar right relating to the Investor  or
by which the Investor may be bound or affected.

      (e)  Litigation.  There is no Action pending that seeks  to
prevent, enjoin, alter or delay the transactions contemplated  by
this Agreement.

      (f)   Purchase for Own Account.  The Purchased  Shares  are
being acquired for investment for the Investor's own account, not
as  a  nominee or agent, and not with a view to the public resale
or distribution thereof within the meaning of the Securities Act,
and  the  Investor has no present intention of selling,  granting
any  participation in, or otherwise distributing the  same.   The
Investor  also  represents that it has not been  formed  for  the
specific purpose of acquiring the Purchased Shares.

      (g)   Investment Experience.  The Investor understands that
the  purchase of the Purchased Shares involves substantial  risk.
The  Investor  has  experience as an investor  in  securities  of
companies  and acknowledges that it is able to fend  for  itself,
can  bear  the  economic risk of its investment in the  Purchased
Shares  and  has  such knowledge and experience in  financial  or
business matters that it is capable of evaluating the merits  and
risks  of  this investment in the Purchased Shares and protecting
its own interests in connection with this investment.

      (h)   Accredited  Investor  Status.   The  Investor  is  an
"accredited   investor"  within  the  meaning  of  Regulation   D
promulgated   under   the   Securities   Act.    The   Investor's
headquarters are located in the State of California.

      (i)   Restricted Securities.  The Investor understands that
the Purchased Shares are characterized as "restricted securities"
under  the  Securities Act, inasmuch as they are  being  acquired
from the Company in a transaction not involving a public offering
and  that  under  the  Securities Act and applicable  regulations
thereunder  such  securities may be resold  without  registration
under  the  Securities Act only in certain limited circumstances.
The Investor is

<PAGE> 11

familiar  with Rule 144 of the SEC, as presently in  effect,  and
understands  the resale limitations imposed thereby  and  by  the
Securities Act.

     (j)  Legends.  The Investor agrees that the certificates for
the Purchased Shares shall bear the following legend:

          "The  shares represented by this certificate  have  not
          been  registered under the Securities Act  of  1933  or
          with  any state securities commission, and may  not  be
          transferred  or  disposed  of  by  the  holder  in  the
          absence  of a registration statement which is effective
          under  the Securities Act of 1933 and applicable  state
          laws  and rules, or, unless, immediately prior  to  the
          time  set  for transfer, such transfer may be  effected
          without  violation of the Securities Act  of  1933  and
          other applicable state laws and rules."

In  addition, the Investor agrees that the Company may place stop
transfer  orders  with its transfer agents with respect  to  such
certificates.  The appropriate portion of the legend and the stop
transfer  orders  will be removed promptly upon delivery  to  the
Company  of  such  satisfactory evidence  as  reasonably  may  be
required by the Company that such legend or stop orders  are  not
required to ensure compliance with the Securities Act.

5.   CONDITIONS TO THE INVESTOR'S OBLIGATIONS AT CLOSING.

The  obligations of the Investor under this Agreement are subject
to  the fulfillment or waiver, on or before the Closing, of  each
of the following conditions:

      (a)   Representations and Warranties  True.   Each  of  the
representations  and  warranties  of  the  Company  contained  in
Section  3 shall be true and correct in all material respects  on
and  as  of  the date of the Disclosure Schedule (as  defined  in
Section 7(a)) and on and as of the date of the Closing, except as
set  forth  in the Disclosure Schedule, with the same  effect  as
though  such representations and warranties had been made  as  of
the Closing.

      (b)   Performance.   The Company shall have  performed  and
complied   with   all  agreements,  obligations  and   conditions
contained in this Agreement that are required to be performed  or
complied  with  by  it on or before the Closing  and  shall  have
obtained all approvals, consents and qualifications necessary  to
complete the purchase and sale described herein.

      (c)   Securities  Exemptions. The offer  and  sale  of  the
Purchased Shares to the Investor pursuant to this Agreement shall
be  exempt  from the registration requirements of the  Securities
Act and the registration and/or qualification requirements of all
applicable state securities laws.

      (d)   Proceedings and Documents.  All corporate  and  other
proceedings  in connection with the transactions contemplated  at
the   Closing  and  all  documents  incident  thereto  shall   be
reasonably  satisfactory in form and substance to  the  Investor,
and  the  Investor  shall  have  received  all  such  counterpart
originals and certified or other copies of such documents  as  it
may reasonably request.  Such documents shall include but not  be
limited to the following:

<PAGE> 12

           (i)   Certified Charter Documents.  A copy of (i)  the
Certificate of Incorporation certified as of a recent date by the
Secretary  of  State of Delaware as a complete and  correct  copy
thereof,  and (ii) the Bylaws of the Company (as amended  through
the Closing Date) certified by the Secretary of the Company as  a
true and correct copy thereof as of the Closing Date.

           (ii)  Board  Resolutions.  A copy,  certified  by  the
Secretary  of  the  Company,  of the  resolutions  of  the  Board
providing for the approval of this Agreement and the issuance  of
the Purchased Shares and the other matters contemplated hereby.

      (e)   Opinion of Company Counsel.  The Investor  will  have
received  an opinion on behalf of the Company, dated the  Closing
Date, from Davis, Graham & Stubbs LLP, counsel to the Company, in
the form attached hereto as Exhibit A.

      (f)   Nasdaq  Requirements.  All requirement of  Nasdaq  in
connection  with the transactions contemplated by this  Agreement
shall  have  been  complied with by the Company.   The  Purchased
Shares shall have been approved for quotation on Nasdaq.

      (g)   Execution  and  Delivery of License  Agreement.   The
Company  shall  have executed and delivered that certain  License
Agreement  with respect to the transactions contemplated  by  the
Term Sheet dated September 15, 1999 (the "License Agreement").

      (h)   Payment of Expense Reimbursement.  The Company  shall
have  paid  the Investor the amount of $15,000 as a reimbursement
of  the Investor's legal fees and expenses in connection with the
transactions contemplated hereby.

      (i)   Other Actions.  The Company shall have executed  such
certificates,  agreements, instruments and other  documents,  and
taken  such  other  actions as shall be customary  or  reasonably
requested  by  the  Investor in connection with the  transactions
contemplated hereby.

6.    CONDITIONS  TO THE COMPANY'S OBLIGATIONS AT  CLOSING.   The
obligations  of the Company to the Investor under this  Agreement
are  subject  to  the fulfillment or waiver,  on  or  before  the
Closing, of each of the following conditions:

        (a)    Representations   and   Warranties   True.     The
representations  and  warranties of  the  Investor  contained  in
Section  4 shall be true and correct in all material respects  on
and  as  of  the  date hereof and on and as of the  date  of  the
Closing  with the same effect as though such representations  and
warranties had been made as of the Closing.

      (b)   Performance.  The Investor shall have  performed  and
complied   with   all  agreements,  obligations  and   conditions
contained in this Agreement that are required to be performed  or
complied  with  by  it on or before the Closing  and  shall  have
obtained all approvals, consents and qualifications necessary  to
complete the purchase and sale described herein.

      (c)   Payment of Purchase Price.  The Investor  shall  have
delivered  to  the  Company the Purchase Price  as  specified  in
Section 1(b).

<PAGE> 13

      (d)   Securities  Exemptions.  The offer and  sale  of  the
Purchased Shares to the Investor pursuant to this Agreement shall
be  exempt  from the registration requirements of the  Securities
Act and the registration and/or qualification requirements of all
applicable state securities laws.

      (e)   Proceedings and Documents.  All corporate  and  other
proceedings  in connection with the transactions contemplated  at
the Closing and all documents incident thereto will be reasonably
satisfactory  in  form  and substance to  the  Company,  and  the
Company  will  have received all such counterpart  originals  and
certified  or other copies of such documents as it may reasonably
request.

      (f)   Nasdaq Requirements.  All requirements of  Nasdaq  in
connection  with the transactions contemplated by this  Agreement
shall have been complied with.

      (g)   Execution  and  Delivery of License  Agreement.   The
Investor shall have executed and delivered the License Agreement.

      (h)   Other Actions.  The Investor shall have executed such
certificates,  agreements, instruments and other  documents,  and
taken  such  other  actions as shall be customary  or  reasonably
requested  by  the  Company in connection with  the  transactions
contemplated hereby.

7.   COVENANTS OF THE PARTIES.

      (a)  Disclosure Schedule.  On or prior to the Closing Date,
the  Company  has delivered to the Investor a disclosure  letter,
which  shall set forth exceptions, if any, to the representations
and warranties made by the Company in Article 3.  Such disclosure
letter   is  organized  such  that  any  exceptions  specifically
identify  the representation and warranty, by section,  to  which
they relate, and clearly identify the nature of the exception, to
the   Investor's   reasonable   satisfaction   (the   "Disclosure
Schedule").   In  any determination of whether  the  Investor  is
entitled to indemnification for the breach of any representations
or  warranties  set forth in this Agreement, only the  Disclosure
Schedule  (i.e., the final disclosure letter agreed upon  by  the
Company   and   the   Investor)  shall  be  relevant,   and   the
identification  of  any matters on any drafts of  the  Disclosure
Schedule shall not be introduced as evidence or otherwise used in
any manner in connection therewith.

     (b)  Information Rights.

           (i)  Financial Information.  The Company covenants and
agrees that, commencing on the Closing Date and continuing for so
long  as  the  Investor holds any Purchased Shares,  the  Company
shall:

                (A)   Annual  Reports.  Furnish to  the  Investor
promptly following the filing of such report with the SEC a  copy
of  the  Company's Annual Report on Form 10-KSB for  each  fiscal
year, which shall include a consolidated balance sheet as of  the
end of such fiscal year, a consolidated statement of income and a
consolidated  statement of cash flows of  the  Company  for  such
year,  setting forth in each case in comparative form the figures
from  the  Company's  previous  fiscal  year,  all  prepared   in
accordance with GAAP and generally

<PAGE> 14

accepted   accounting  practices,  and  audited  by   nationally-
recognized  independent  certified public  accountants.   In  the
event  the  Company shall no longer be required  to  file  Annual
Reports  on  Form 10-KSB, the Company shall, within  ninety  (90)
days following the end of each respective fiscal year, deliver to
the  Investor a copy of such balance sheets, statements of income
and statements of cash flows.

                (B)   Quarterly Reports.  Furnish to the Investor
promptly following the filing of such report with the SEC, a copy
of  each of the Company's Quarterly Reports on Form 10-QSB, which
shall  include a consolidated balance sheet as of the end of  the
respective fiscal quarter, consolidated statements of income  and
cash  flows of the Company for the respective fiscal quarter  and
for  the  year to-date, setting forth in each case in comparative
form  the  figures from the comparable periods in  the  Company's
immediately  preceding  fiscal year, all prepared  in  accordance
with GAAP and generally accepted accounting practices (except, in
the  case  of  any Form 10-QSB, as may otherwise be permitted  by
Form 10-Q), but all of which may be unaudited.  In the event  the
Company shall no longer be required to file Quarterly Reports  on
Form  10-QSB,  the  Company shall, within  forty-five  (45)  days
following the end of each of the first three (3) fiscal  quarters
of  each  fiscal  year, deliver to the Investor a  copy  of  such
balance  sheets,  statements of income  and  statements  of  cash
flows.

           (ii)  SEC  Filings. The Company shall deliver  to  the
Investor  copies of each other document filed with the SEC  on  a
non-confidential  basis promptly following  the  filing  of  such
document with the SEC.

     (c)  Registration Rights.

          (i)  Definitions.  For purposes of this Section 7(c):

                 (A)    Registration.   The   terms   "register,"
"registered," and "registration" refer to a registration effected
by  preparing  and filing a registration statement in  compliance
with  the  Securities  Act, and the declaration  or  ordering  of
effectiveness of such registration statement.

                  (B)     Registrable   Securities.    The   term
"Registrable  Securities"  means:   (x)  the  Purchased   Shares;
(y)  any  other shares of Common Stock acquired by  the  Investor
after the date hereof which are not already freely tradable under
the Securities Act (pursuant to Rule 144(k) promulgated under the
Securities  Act);  and (z) any shares of Common  Stock  or  other
securities  of  the  Company issued  as  (or  issuable  upon  the
conversion  or  exercise of any warrant, right or other  security
that  is issued as) a dividend or other distribution with respect
to,  or  in  exchange  for  or  in replacement  of,  any  of  the
securities described in the immediately preceding Clause  (x)  or
(y).   Notwithstanding  the  foregoing, "Registrable  Securities"
shall  exclude  any Registrable Securities sold by  a  person  or
entity  in a transaction in which rights under this Section  7(c)
are  not  assigned  in  accordance with  this  Agreement  or  any
Registrable  Securities sold in a public offering,  whether  sold
pursuant to Rule 144 promulgated under the Securities Act, or  in
a registered offering, or otherwise.

               (C)  Registrable Securities Then Outstanding.  The
number  of  shares  of "Registrable Securities then  outstanding"
shall mean the number of Purchased Shares,

<PAGE> 15

other  shares  of  Common  Stock and other  securities  that  are
Registrable Securities and are then issued and outstanding.

                (D)   Holder.  For purposes of this Section 7(c),
the  term  "Holder" means any person or entity owning  of  record
Registrable Securities that have not been sold to the  public  or
pursuant to Rule 144 promulgated under the Securities Act or  any
permitted  assignee of record of such Registrable  Securities  to
whom  rights  under this Section 7(c) have been duly assigned  in
accordance with this Agreement.

                (E)   Form  S-3.  The term "Form S-3" means  such
form  under the Securities Act as is in effect on the date hereof
or  any  successor  registration form under  the  Securities  Act
subsequently  adopted  by  the  SEC  that  permits  inclusion  or
incorporation  of substantial information by reference  to  other
documents filed by the Company with the SEC.

          (ii) Demand Registration.

                (A)   Request by Holders.  If, at any time  after
the  date  which is four (4) months after the Closing  Date,  the
Company  shall, following the Closing, receive a written  request
from  the  Holders of at least twenty-five percent (25%)  of  the
Purchased Shares issued at the Closing, that the Company  file  a
registration statement under the Securities Act on Form  S-3,  or
any  successor form (including a "shelf" registration  statement,
if  requested  by such Holders, during any period  of  time  that
Rule  144  is  not available as an exemption for the  sale  in  a
single  90-day  period of all of the Registrable Securities  that
any  such Holder desires to sell, in which case the Company would
maintain the effectiveness of such "shelf" registration statement
until  all  such  Registrable  Securities  could  be  sold  under
Rule 144 in a single 90-day period) covering the registration  of
Registrable Securities (provided that such Form S-3 or  successor
form  shall also contain any information required to be  included
on  Form  S-1  that  the  Investor may  in  its  sole  discretion
request),  then the Company shall, within ten (10) business  days
of  the  receipt of such written request, give written notice  of
such   request  ("Request  Notice")  to  all  Holders,  and   use
commercially   reasonable  efforts  to   effect,   as   soon   as
practicable,  the registration under the Securities  Act  of  all
Registrable Securities that Holders request to be registered  and
included  in  such registration by written notice given  by  such
Holders  to the Company within twenty (20) days after receipt  of
the Request Notice; provided, however, that the Company shall not
be  obligated to effect any such registration if the Company has,
within  the  six  (6) month period preceding  the  date  of  such
request, already effected a registration under the Securities Act
pursuant  to  Section 7(c)(iii), other than a  registration  from
which  the  Registrable Securities of Holders have been  excluded
with  respect to all or any portion of the Registrable Securities
the Holders requested be included in such registration.

                (B)  Underwriting.  If the Holders initiating the
registration  request  under this Section  7(c)(ii)  ("Initiating
Holders") intend to distribute the Registrable Securities covered
by  their request by means of an underwriting, then they shall so
advise  the  Company as a part of their request, and the  Company
shall include such information in the written notice referred  to
in  Section 7(c)(ii)(A).  In such event, the right of any  Holder
to include his or her Registrable Securities in such registration
shall  be  conditioned upon such Holder's participation  in  such
underwriting  and  the  inclusion of  such  Holder's  Registrable
Securities in the underwriting (unless otherwise mutually  agreed
by a majority in interest of the initiating Holders

<PAGE> 16

and  such  Holder determined based on the number  of  Registrable
Securities  held by such Holders being registered).  All  Holders
proposing to distribute their Registrable Securities through such
underwriting  shall  enter  into  an  underwriting  agreement  in
customary  form  with  the managing underwriter  or  underwriters
selected  for such underwriting by the Holders of a  majority  of
the   Registrable  Securities  being  registered  and  reasonably
acceptable to the Company (including a market stand-off agreement
of   up   to   90   days  if  required  by  such   underwriters).
Notwithstanding any other provision of this Section 7(c)(ii),  if
the   underwriter(s)  advise(s)  the  Company  in  writing   that
marketing   factors  require  a  limitation  of  the  number   of
securities  to be underwritten then the Company shall  so  advise
all  Holders  of Registrable Securities that would  otherwise  be
registered  and underwritten pursuant hereto, and the  number  of
Registrable  Securities that may be included in the  underwriting
shall  be reduced as required by the underwriter(s) and allocated
among  the Holders of Registrable Securities on a pro rata  basis
according   to   the  number  of  Registrable   Securities   then
outstanding   held   by   each  Holder  requesting   registration
(including the initiating Holders); provided, however,  that  the
number of shares of Registrable Securities to be included in such
underwriting  and  registration shall not be reduced  unless  all
other  securities  of the Company and any selling  securityholder
who is a director, officer, employee, consultant or affiliate  of
the Company are first entirely excluded from the underwriting and
registration.  Any Registrable Securities excluded and  withdrawn
from such underwriting shall be withdrawn from the registration.

                (C)  Maximum Number of Demand Registrations.  The
Company  shall be obligated to effect only three (3) registration
pursuant to this Section 7(c)(ii).

                (D)  Deferral.  Notwithstanding the foregoing, if
the  Company shall furnish to Holders requesting the filing of  a
registration  statement  pursuant  to  this  Section  7(c)(ii)  a
certificate signed by the President or Chief Executive Officer of
the Company stating that in the good faith judgment of the Board,
it  would  be  materially  detrimental to  the  Company  and  its
stockholders  for such registration statement to be  filed,  then
the  Company  shall  have the right to defer such  filing  for  a
period  of  not  more than sixty (60) days after receipt  of  the
request  of the initiating Holders; provided, however,  that  the
Company  may not utilize this right more than once in any  twelve
(12) month period.

                 (E)    Expenses.   All  expenses   incurred   in
connection    with    any   registration   pursuant    to    this
Section   7(c)(ii),  including  all  federal   and   "blue   sky"
registration,  filing  and  qualification  fees,  printer's   and
accounting  fees, and fees and disbursements of counsel  for  the
Company  (but  excluding underwriters' discounts and  commissions
relating  to shares sold by the Holders), shall be borne  by  the
Company.  Each Holder participating in a registration pursuant to
this  Section  7(c)(ii)  shall bear such  Holder's  proportionate
share  (based  on  the  total  number  of  shares  sold  in  such
registration other than for the account of the Company or any  of
its  directors, officers, employees, consultants and  affiliates)
of  all  discounts,  commissions  or  other  amounts  payable  to
underwriters or brokers in connection with such offering  by  the
Holders.  Notwithstanding the foregoing, the Company shall not be
required  to pay for any expenses of any registration  proceeding
begun  pursuant  to  this Section 7(c)(ii)  if  the  registration
request  is subsequently withdrawn at the request of the  Holders
of  a  majority  of the Registrable Securities to be  registered,
unless  the Holders of such majority agree that such registration
constitutes the use by the Holders of one (1) demand registration
pursuant   to   this  Section  7(c)(ii)  (in  which   case   such
registration  shall also constitute the use  by  all  Holders  of
Registrable Securities of one (l)

<PAGE> 17

such  demand registration); provided further, that if at the time
of  such  withdrawal,  the Holders have  learned  of  a  material
adverse  change  relating to the Company  or  the  United  States
financial markets not known to the Holders at the time  of  their
request  for  such registration and have withdrawn their  request
for  registration after learning of such material adverse change,
then  the  Holders  shall not be required  to  pay  any  of  such
expenses and such registration shall not constitute the use of  a
demand registration pursuant to this Section 7(c)(ii).

           (iii)     Piggyback Registrations.  The Company  shall
notify all Holders of Registrable Securities in writing at  least
twenty (20) days prior to filing any registration statement under
the Securities Act for purposes of effecting a public offering of
securities  of  the  Company (including  registration  statements
relating to secondary offerings of securities of the Company, but
excluding  registration  statements  relating  to  any   employee
benefit plan or any merger or other corporate reorganization, any
registration  statement under Rule 462(b) filed with  respect  to
any   effective  registration  statement  and  one   registration
statement filed with the SEC on or before November 30, 1999  with
respect  to  the resale of shares issued in connection  with  the
Company's acquisition of Technologic, Inc.) and will afford  each
such  Holder  an  opportunity  to include  in  such  registration
statement all or any part of the Registrable Securities then held
by  such  Holder.  Each Holder desiring to include  in  any  such
registration  statement  all  or  any  part  of  the  Registrable
Securities  held by such Holder shall, within ten  (10)  business
days  after  receipt  of  the  above-described  notice  from  the
Company,  so  notify the Company in writing, and in  such  notice
shall  inform the Company of the number of Registrable Securities
such Holder wishes to include in such registration statement.  If
a Holder decides not to include all of its Registrable Securities
in  any  registration statement thereafter filed by the  Company,
such  Holder  shall nevertheless continue to have  the  right  to
include any Registrable Securities in any subsequent registration
statement  or  registration statements as may  be  filed  by  the
Company with respect to offerings of its securities, all upon the
terms  and  conditions  set  forth herein.   Notwithstanding  the
foregoing, the Holders of Registrable Securities shall  not  have
the rights set forth in this Section 7(c)(iii) in connection with
any  registration  statement demanded by Brown Simpson  Strategic
Growth  Fund, L.P. or Brown Simpson Strategic Growth  Fund,  Ltd.
(collectively,  the "Brown Simpson Entities")  pursuant  to  that
certain  Registration Rights Agreement dated June 10, 1999  among
the Company and the Brown Simpson Entities.

                (A)   Underwriting.  If a registration  statement
under which the Company gives notice under this Section 7(c)(iii)
is for an underwritten offering, then the Company shall so advise
the  Holders of Registrable Securities.  In such event, the right
of  any  such  Holder's Registrable Securities to be included  in
such  a  registration  shall be conditioned  upon  such  Holder's
participation  in  such underwriting and the  inclusion  of  such
Holder's Registrable Securities in the underwriting to the extent
provided  herein.   All  Holders proposing  to  distribute  their
Registrable Securities through such underwriting shall enter into
an  underwriting  agreement in customary form with  the  managing
underwriter   or  underwriters  selected  for  such  underwriting
(including  a  market stand-off agreement of up  to  90  days  if
required by such underwriters); provided, however, that it  shall
not  be  considered customary to require any of  the  Holders  to
provide  representations and warranties regarding the Company  or
indemnification of the underwriters for material misstatements or
omissions  in the registration statement or prospectus  for  such
offering.  Notwithstanding any other provision of this Agreement,
if  the  managing  underwriter determine(s) in  good  faith  that
marketing factors require a limitation of the number of shares to
be underwritten, then the managing underwriter(s) may

<PAGE> 18

exclude  shares  from  the  registration  and  the  underwriting;
provided,  however,  that the securities to be  included  in  the
registration and the underwriting shall be allocated as  follows:
(1)  first  to the Company (provided, however, that a minimum  of
fifteen  percent  (15%)  of the number of Registrable  Securities
held  by  each Holder (where any Registrable Securities that  are
not  shares  of Common Stock but are exercisable or  exchangeable
for, or convertible into, shares of Common Stock, shall be deemed
to  have  been  so  exercised, exchanged or  converted  for  such
purpose) must also in any event be included if requested  by  any
such  Holder); (2) second, to the extent the managing underwriter
determines additional securities can be included after compliance
with  Clause  (1),  to each of the Holders  (to  the  extent  not
included  pursuant to Clause (1)) requesting inclusion  of  their
Registrable Securities in such registration statement  on  a  pro
rata  basis  based on the total number of Registrable  Securities
and  other securities entitled to registration then held by  each
such   Holder;  and  (3)  third,  to  the  extent  the   managing
underwriter  determines  additional securities  can  be  included
after  compliance with Clauses (1) and (2), any other  shares  of
Common Stock or other securities of the Company.  Any Registrable
Securities excluded or withdrawn from such underwriting shall  be
excluded  and  withdrawn from the registration.  For  any  Holder
that  is  a partnership, the Holder and the partners and  retired
partners of such Holder, or the estates and family members of any
such partners and retired partners and any trusts for the benefit
of  any  of the foregoing persons, and for any Holder that  is  a
corporation, the Holder and all corporations that are  affiliates
of  such Holder, shall be deemed to be a single "Holder," and any
pro  rata reduction with respect to such "Holder" shall be  based
upon  the aggregate amount of shares carrying registration rights
owned  by all entities and individuals included in such "Holder,"
as defined in this sentence.

                 (B)    Expenses.   All  expenses   incurred   in
connection with a registration pursuant to this Section 7(c)(iii)
(excluding  underwriters' and brokers' discounts and  commissions
relating  to  shares sold by the Holders), including all  federal
and  "blue  sky"  registration, filing  and  qualification  fees,
printers'  and  accounting fees, and fees  and  disbursements  of
counsel for the Company, shall be borne by the Company.  Fees and
disbursements of any counsel for the Holders shall  be  borne  by
the Holders.

                 (C)    Not  Demand  Registration.   Registration
pursuant to this Section 7(c)(iii) shall not be deemed  to  be  a
demand registration as described in Section 7(c)(ii).  Except  as
otherwise provided herein, there shall be no limit on the  number
of  times  the  Holders may request registration  of  Registrable
Securities under this Section 7(c)(iii).

           (iv)  Form  S-3  Registration.  If  requested  by  the
Holders  of  at least twenty-five percent (25%) of the  Purchased
Shares  issued  at  the  Closing,  the  Company  shall  use   all
reasonable  commercial efforts to cause to be  filed  and  become
effective  with  the SEC by the one hundred twenty-first  (121st)
day following the Closing Date a Registration Statement on Form S-
3  relating  to all of the Registrable Securities (in  the  event
such  registration statement is not effective on such  date,  the
Company shall continue to use all commercially reasonable efforts
to  cause  it  to  become effective until it becomes  effective);
provided, however, that in the event Form S-3 is not available to
the  Company, the Company shall file such other form  as  may  be
available  if  Holders  who hold Registrable  Securities  with  a
market value of at least Five Hundred Thousand Dollars ($500,000)
deliver a written request to the Company that the Company do  so,
where  such  market value is determined as of the  date  of  such
written   request.   The  Company  shall  use  its   commercially
reasonable  efforts to cause any such Registration  Statement  to
become

<PAGE> 19

effective  as  promptly as possible after such filing  and  shall
also  use  its  commercially reasonable  efforts  to  obtain  any
related  qualifications, registrations or other compliances  that
may  be  necessary  under any applicable  "blue  sky"  laws.   In
connection with such registration, the Company will:

                (A)  Notice.  Promptly give written notice to the
Holders   of   the   proposed  registration   and   any   related
qualification or compliance.

                (B)  Registration.  Effect such registration  and
all  such  qualifications and compliances and as would permit  or
facilitate  the sale and distribution of all or such  portion  of
such Holder's or Holders' Registrable Securities on and after the
one hundred and twentieth (120th) day following the Closing Date;
provided,  however, that the Company shall not  be  obligated  to
effect   any   such  registration,  qualification  or  compliance
pursuant  to this Section 7(c)(iv) in any particular jurisdiction
in  which the Company would be required to qualify to do business
or  to  execute  a  general  consent to  service  of  process  in
effecting such registration, qualification or compliance.

               (C)  Expenses.  The Company shall pay all expenses
incurred  in connection with each registration requested pursuant
to  this  Section 7(c)(iv), excluding underwriters'  or  brokers'
discounts and commissions relating to shares sold by the Holders,
including  federal  and  "blue  sky"  registration,  filing   and
qualification fees, printers' and accounting fees, and  fees  and
disbursements of counsel for the Company.  Fees and disbursements
of any counsel for the Holders shall be borne by the Holders.

                (D)  Deferral.  Notwithstanding the foregoing, if
the  Company shall furnish to Holders requesting the filing of  a
registration  statement  pursuant to  this  Section  7(c)(iv),  a
certificate signed by the President or Chief Executive Officer of
the Company stating that in the good faith judgment of the Board,
it  would  be  materially  detrimental to  the  Company  and  its
stockholders  for such registration statement to be  filed,  then
the  Company  shall  have the right to defer such  filing  for  a
period  of  not  more than sixty (60) days after receipt  of  the
request  of the initiating Holders; provided, however,  that  the
Company  may not utilize this right more than once in any  twelve
(12)  month  period, and the period of time that the  Company  is
obligated  to  maintain  the effectiveness  of  any  registration
statement under Clause (F) below shall be extended for the length
of any such period of deferral.

                 (E)    Not   Demand  Registration.    Form   S-3
registrations  shall not be deemed to be demand registrations  as
described in Section 7(c)(ii) above.

                (F)   Maintenance.  Subject to Section  7(c)(vi),
the  Company  shall  use all commercially reasonable  efforts  to
maintain the effectiveness of any Form S-3 registration statement
filed under this Section 7(c)(iv) until the earlier of:  (1)  the
date  on which all of the Registrable Securities have been  sold;
and  (2)  the  first anniversary of the effective  date  of  such
registration statement; provided, however, that unless all of the
Registrable  Securities held by the Investor  as  of  such  first
anniversary  could  then  be  sold in  a  single  transaction  in
accordance  with  Rule  144  under  the  Securities  Act  without
exceeding the volume limitations thereof, if the Company receives
written notice from the Investor that the Investor may be  deemed
to  be  an  "affiliate"  of  the  Company  for  purposes  of  the
Securities Act, the date in this

<PAGE> 20

Clause  (2)  shall  be  extended until the Investor  advises  the
Company  that  it  no longer believes it may be  deemed  such  an
"affiliate."

           (v)  Obligations of the Company.  Whenever required to
effect the registration of any Registrable Securities under  this
Agreement  the  Company  shall, as  expeditiously  as  reasonably
possible:

                (A)   Registration Statement.  Prepare  and  file
with  the  SEC  a  registration statement with  respect  to  such
Registrable  Securities  and  use  all  commercially   reasonable
efforts to cause such registration statement to become effective;
provided, however, that, except as otherwise required by in  this
Section 7(c), the Company shall not be required to keep any  such
registration statement effective for more than ninety (90) days.

               (B)  Amendments and Supplements.  Prepare and file
with the SEC such amendments and supplements to such registration
statement  and  the  prospectus  used  in  connection  with  such
registration  statement as may be necessary to  comply  with  the
provisions  of the Securities Act with respect to the disposition
of all securities covered by such registration statement.

                (C)   Prospectuses.  Furnish to the Holders  such
number  of  copies  of  a  prospectus,  including  a  preliminary
prospectus, in conformity with the requirements of the Securities
Act,  and such other documents as they may reasonably request  in
order to facilitate the disposition of the Registrable Securities
owned by them that are included in such registration.

                (D)   Blue  Sky.  Use all commercially reasonable
efforts  to register and qualify the securities covered  by  such
registration statement under such other securities  or  Blue  Sky
laws  of  such jurisdictions as shall be reasonably requested  by
the  Holders, provided that the Company shall not be required  in
connection therewith or as a condition thereto to qualify  to  do
business  or to file a general consent to service of  process  in
any such states or jurisdictions.

                 (E)    Underwriting.   In  the  event   of   any
underwritten  public  offering,  enter  into  and   perform   its
obligations  under  an  underwriting  agreement  in   usual   and
customary  form  (including  customary  indemnification  of   the
underwriters by the Company), with the managing underwriter(s) of
such  offering.   Each Holder participating in such  underwriting
shall  also enter into and perform its obligations under such  an
agreement.

                 (F)    Notification.   Notify  each  Holder   of
Registrable Securities covered by such registration statement  at
any  time  when a prospectus relating thereto is required  to  be
delivered under the Securities Act of the happening of any  event
as a result of which the prospectus included in such registration
statement, as then in effect, includes an untrue statement  of  a
material  fact or omits to state a material fact required  to  be
stated  therein or necessary to make the statements  therein  not
misleading  in the light of the circumstances then  existing,  in
which  event  no Holder shall use such prospectus  in  connection
with  any offer or sale of its Registrable Securities until  such
prospectus has been appropriately amended (which the

<PAGE> 21

Company shall promptly under the circumstances do and deliver new
prospectuses, as requested by the Holders, promptly thereafter).

                (G)  Opinion and Comfort Letter.  Furnish, at the
request  of  any  Holder requesting registration  of  Registrable
Securities,  on  the  date that such Registrable  Securities  are
delivered  to  the underwriters for sale, if such securities  are
being  sold through underwriters, or, if such securities are  not
being   sold   through  underwriters,  on  the  date   that   the
registration  statement with respect to such  securities  becomes
effective, (1) an opinion, dated as of such date, of the  counsel
representing  the Company for the purposes of such  registration,
in  form and substance as is customarily given to underwriters in
an underwritten public offering and reasonably satisfactory to  a
majority  in  interest  of  the Holders requesting  registration,
addressed  to  the  underwriters, if  any,  and  to  the  Holders
requesting registration of Registrable Securities and (2) in  the
event that such securities are being sold through underwriters, a
"comfort"  letter  dated as of such date,  from  the  independent
certified  public  accountants  of  the  Company,  in  form   and
substance as is customarily given by independent certified public
accountants  to  underwriters in an underwritten public  offering
and  reasonably  satisfactory to a majority in  interest  of  the
Holders  requesting registration, addressed to  the  underwriters
and   to  the  Holders  requesting  registration  of  Registrable
Securities.

           (vi)  Furnish  Information.  It shall be  a  condition
precedent  to the obligations of the Company to take  any  action
pursuant to Section 7(c)(ii), (iii), (iv) or (v) that the selling
Holders  shall furnish to the Company such information  regarding
themselves,  the  Registrable Securities held by  them,  and  the
intended  method of disposition of such securities  as  shall  be
required  to  timely effect the registration of their Registrable
Securities.

            (vii)       Indemnification.   In   the   event   any
Registrable  Securities are included in a registration  statement
under Section 7(c)(ii), (iii) or (iv):

                (A)  By the Company.  To the extent permitted  by
law,  the  Company will indemnify and hold harmless each  Holder,
the  partners, officers, shareholders, employees, representatives
and  directors of each Holder, any underwriter (as determined  in
the  Securities Act) for such Holder and each person, if any, who
controls  such  Holder or underwriter within the meaning  of  the
Securities  Act or the Exchange Act, against any losses,  claims,
damages,  or  liabilities (joint or several) to  which  they  may
become  subject  under the Securities Act, the  Exchange  Act  or
other  federal  or  state law, insofar as  such  losses,  claims,
damages, or liabilities (or actions in respect thereof) arise out
of  or  are based upon any of the following statements, omissions
or violations (collectively a "Violation"):

                     (x)   any untrue statement or alleged untrue
statement  of  a  material fact contained  in  such  registration
statement,   including  any  preliminary  prospectus   or   final
prospectus  contained  therein or any amendments  or  supplements
thereto;

                     (y)   the  omission or alleged  omission  to
state  therein a material fact required to be stated therein,  or
necessary to make the statements therein not misleading; or

<PAGE> 22

                     (z)   any violation or alleged violation  by
the  Company of the Securities Act, the Exchange Act, any federal
or  state  securities  law or any rule or regulation  promulgated
under  the  Securities Act, the Exchange Act or  any  federal  or
state  securities law in connection with the offering covered  by
such registration statement;

and  the  Company  will  reimburse  each  such  Holder,  partner,
officer,   shareholder,   employee,   representative,   director,
underwriter or controlling person for any legal or other expenses
reasonably  incurred  by them, as incurred,  in  connection  with
investigating   or  defending  any  such  loss,  claim,   damage,
liability  or  action;  provided,  however,  that  the  indemnity
agreement contained in this paragraph shall not apply to  amounts
paid in settlement of any such loss, claim, damage, liability  or
action if such settlement is effected without the consent of  the
Company  (which consent shall not be unreasonably withheld),  nor
shall  the Company be liable in any such case for any such  loss,
claim,  damage, liability or action to the extent that it  arises
out  of or is based upon a Violation that occurs in reliance upon
and  in  conformity with written information furnished  expressly
for  use  in  connection with such registration by  such  Holder,
partner,    officer,   shareholder,   employee,   representative,
director, underwriter or controlling person of such Holder.

                (B)   By  the  Selling Holders.   To  the  extent
permitted  by  law, each selling Holder will indemnify  and  hold
harmless the Company, each of its directors, each of its officers
who  have signed the registration statement, each person, if any,
who  controls  the Company within the meaning of  the  Securities
Act,  any  underwriter  and any other Holder  selling  securities
under  such registration statement or any of such other  Holder's
partners, officers, shareholders, employees, representatives  and
directors  and  any  person who controls such Holder  within  the
meaning  of  the Securities Act or the Exchange Act, against  any
losses,  claims,  damages or liabilities (joint  or  several)  to
which  the  Company or any such officer or director,  controlling
person,  underwriter  or  other such  Holder,  partner,  officer,
shareholder,  employee, representative, director  or  controlling
person  of  such  other  Holder  may  become  subject  under  the
Securities  Act, the Exchange Act or other federal or state  law,
insofar  as  such  losses,  claims, damages  or  liabilities  (or
actions  in respect thereto) arise out of or are based  upon  any
Violation,  in each case to the extent (and only to  the  extent)
that  such  Violation occurs in reliance upon and  in  conformity
with  written information furnished by such Holder expressly  for
use  in  connection with such registration; and each such  Holder
will reimburse any legal or other expenses reasonably incurred by
the  Company or any such officer or director, controlling person,
underwriter  or  other  Holder,  partner,  officer,  shareholder,
employee, representative, director or controlling person of  such
other  Holder  in connection with investigating or defending  any
such loss, claim, damage, liability or action; provided, however,
that  the  indemnity agreement contained in this paragraph  shall
not  apply to amounts paid in settlement of any such loss, claim,
damage,  liability  or  action  if such  settlement  is  effected
without  the  consent of the Holder, which consent shall  not  be
unreasonably  withheld;  and provided  further,  that  the  total
amounts payable in indemnity by a Holder under this subsection or
otherwise  in respect of any and all Violations shall not  exceed
in  the aggregate the net proceeds received by such Holder in the
registered offering out of which such Violations arise.

                 (C)   Notice.   Promptly  after  receipt  by  an
indemnified  party  under of notice of the  commencement  of  any
action  (including  any  governmental action),  such  indemnified
party  will, if a claim in respect thereof is to be made  against
any indemnifying party

<PAGE> 23

under  this section, deliver to the indemnifying party a  written
notice  of  the  commencement thereof and the indemnifying  party
shall  have  the right to participate in, and, to the extent  the
indemnifying   party   so  desires,  jointly   with   any   other
indemnifying  party  similarly noticed,  to  assume  the  defense
thereof  with  counsel  mutually  satisfactory  to  the  parties;
provided, however, that an indemnified party shall have the right
to  retain its own counsel, with the fees and expenses to be paid
by  the indemnifying party, to the extent that representation  of
such   indemnified  party  by  the  counsel   retained   by   the
indemnifying  party  would  be inappropriate  due  to  actual  or
potential  conflict of interests between such  indemnified  party
and   any  other  party  represented  by  such  counsel  in  such
proceeding.   The  failure  to  deliver  written  notice  to  the
indemnifying  party within a reasonable time of the  commencement
of  any such action shall not relieve such indemnifying party  of
liability  except  to  the  extent  the  indemnifying  party   is
prejudiced as a result thereof.

                (D)  Defect Eliminated in Final Prospectus.   The
foregoing  indemnity agreements of the Company  and  Holders  are
subject  to  the condition that, insofar as they  relate  to  any
Violation  made  in  a preliminary prospectus but  eliminated  or
remedied  in the amended prospectus on file with the SEC  at  the
time the registration statement in question becomes effective  or
the  amended  prospectus  filed with  the  SEC  pursuant  to  SEC
Rule  424(b)  (the "Final Prospectus"), such indemnity  agreement
shall  not  inure to the benefit of any person if a copy  of  the
Final  Prospectus  was timely furnished to the indemnified  party
and was not furnished to the person or entity asserting the loss,
liability, claim or damage at or prior to the time such action is
required by the Securities Act.

                (E)   Contribution.  In order to provide for just
and   equitable  contribution  to  joint  liability   under   the
Securities  Act  in  any  case in which  either  (1)  any  Holder
exercising rights under this Agreement, or any controlling person
of any such Holder, makes a claim for indemnification pursuant to
this section, but it is judicially determined (by the entry of  a
final judgment or decree by a court of competent jurisdiction and
the  expiration of time to appeal or the denial of the last right
of  appeal) that such indemnification may not be enforced in such
case  notwithstanding  the fact that this  section  provides  for
indemnification  in  such  case, or (2)  contribution  under  the
Securities  Act may be required on the part of any  such  selling
Holder or any such controlling person in circumstances for  which
indemnification is provided under this section; then, and in each
such  case,  the Company and such Holder will contribute  to  the
aggregate  losses, claims, damages or liabilities to  which  they
may   be  subject  (after  contribution  from  others)  in   such
proportion  so  that such Holder is responsible for  the  portion
represented by the percentage that the public offering  price  of
its   Registrable  Securities  offered  by  and  sold  under  the
registration statement bears to the public offering price of  all
securities offered by and sold under such registration statement,
and the Company and other selling Holders are responsible for the
remaining  portion; provided, however, that, in  any  such  case:
(X)  no such Holder will be required to contribute any amount  in
excess  of  the  public  offering price of all  such  Registrable
Securities  offered  and  sold by such Holder  pursuant  to  such
registration  statement; and (Y) no person or  entity  guilty  of
fraudulent misrepresentation (within the meaning of Section 11(f)
of  the Securities Act) will be entitled to contribution from any
person   or   entity  who  was  not  guilty  of  such  fraudulent
misrepresentation.

               (F)  Survival.  The obligations of the Company and
Holders  under  this Section 7(c)(vii) shall  survive  until  the
fifth (5th) anniversary of the completion of any

<PAGE> 24

offering  of Registrable Securities in a registration  statement,
regardless  of  the expiration of any statutes of  limitation  or
extensions of such statutes.

           (viii)     Termination  of the Company's  Obligations.
The   Company  shall  have  no  obligations  pursuant   to   this
Section  7(c) with respect to any Registrable Securities proposed
to   be   sold  by  a  Holder  in  a  registration  pursuant   to
Section  7(c)(ii), (iii) or (iv) more than three (3) years  after
the  Closing Date or if, in the written opinion of counsel to the
Company, reasonably acceptable to counsel for a Holder, all  such
Registrable Securities proposed to be sold by a Holder  may  then
be  sold  under  Rule  144  in  any three  month  period  without
exceeding the volume limitations thereunder.

           (ix) No Registration Rights to Third Parties.  For  so
long as the Holders directly or indirectly own at least 5% of the
outstanding  voting  stock  of the  Company,  without  the  prior
written consent of the Investor, the Company covenants and agrees
that  it  shall not grant, or cause or permit to be created,  for
the  benefit of any person or entity any registration  rights  of
any  kind (whether similar to the demand, "piggyback" or Form S-3
registration  rights described in this Section 7,  or  otherwise)
relating to shares of Common Stock or any other securities of the
Company  that  are pari passu or superior to the  rights  granted
under this Section 7(c).

       (d)    Obligations  Regarding  Confidential   Information.
Confidential  Information  (as  defined  below)  shall   not   be
disclosed  by  any  party hereto to any  third  party  except  in
accordance with the provisions set forth below.  For purposes  of
this Agreement, the term "Confidential Information" refers to the
following  items:   (i)  the existence  of  this  Agreement,  and
(ii)  the  terms  and  provisions of  this  Agreement;  provided,
however,  that  Confidential Information shall  not  include  any
information  that was (i) publicly known and generally  available
in  the  public  domain prior to its disclosure by  the  Company,
(ii) becomes publicly known and generally available in the public
domain  through no action or inaction on the part of the  Company
or  (iii)  becomes  publicly known by written  consent  or  other
action of the Investor.

           (i)  Press Releases, Etc.  After the Closing Date  and
the  issuance  by the Company of the press release  described  in
subsection  (d)(iv) below, the Company may include in its  future
press releases a statement regarding the Investor's investment in
the  Company, which statement will be provided to the Company  by
the  Investor  and  used  verbatim by  the  Company.   Except  as
provided  in  subsection  (d)(iv) below,  no  other  announcement
regarding  the  Confidential  Information  in  a  press  release,
conference,  advertisement, announcement, professional  or  trade
publication,  Website, mass marketing materials or otherwise  may
be  made without the prior written consent of each of the parties
hereto.

            (ii)  Permitted  Disclosures.   Notwithstanding   the
foregoing,  (i)  any party may disclose any of  the  Confidential
Information  to  its current or bona fide prospective  investors,
employees,   investment   bankers,   lenders,   accountants   and
attorneys,  in each case only where such persons or entities  are
under appropriate nondisclosure obligations (the Company shall be
responsible  for  any  failure of any such person  or  entity  to
comply  with the provisions of this Section 7(d)); and  (ii)  the
Investor  may  disclose its investment in the Company  and  other
Confidential Information to third parties or to the public at its
sole discretion and, if it does so,

<PAGE> 25

the Company shall have the right to disclose to third parties any
such  information disclosed in a press release  or  other  public
announcement by the Investor.

           (iii)     Legally Compelled Disclosure.  Except to the
extent  required  by law or judicial or administrative  order  or
except  as  provided herein, the Company shall not  disclose  any
Confidential  Information  without the Investor's  prior  written
approval;  provided, however, that the Company may  disclose  any
Confidential  Information,  to the  extent  required  by  law  or
judicial   or  administrative  order,  provided  that   if   such
disclosure  is pursuant to judicial or administrative order,  the
Company  will notify the Investor promptly before such disclosure
and  will  cooperate  with  the  Investor  to  seek  confidential
treatment  with  respect to the disclosure if  requested  by  the
Investor;  and  provided  further, that  if  such  disclosure  is
required  pursuant  to law or the rules and  regulations  of  any
federal,  state or local governmental authority or any regulatory
body,  the  parties will cooperate to seek confidential treatment
to  the maximum extent, in the reasonable judgment of counsel  of
the  Company, possible under law.  Notwithstanding the  foregoing
provisions  or any other provision to the contrary,  the  Company
agrees  that,  except  to  the extent  required  by  judicial  or
administrative  order,  which the Company  shall  resist  to  the
maximum extent possible under law, the Company will not file this
Agreement  (the "Exhibit Filing") with any governmental authority
or  any  regulatory body; provided, however, that to  the  extent
required  under the rules and regulations promulgated  under  the
Securities  Act,  upon  the advice of counsel,  the  Company  may
(A)  file this Agreement as an exhibit to any filing required  to
be  made by the Company under the Exchange Act, (B) identify  the
Investor  as  "Intel Corporation" and (C) describe  the  material
terms of the Investor's investment.   The Company agrees that  it
will  provide  the  Investor with drafts of any documents,  press
releases or other filings (including the filing permitted by  the
proviso  of  the  immediately preceding sentence)  in  which  the
Company  desires  to  disclose this Agreement,  the  transactions
contemplated  hereby  or  any other Confidential  Information  is
disclosed at least three (3) business days prior to the filing or
disclosure  thereof, and that it will make any  changes  to  such
materials as requested by the Investor unless advised by  counsel
that  the  rules and regulations promulgated under the Securities
Act  require  otherwise.  Unless permitted by the terms  of  this
Section  7(d),  the  Company will not disclose  any  Confidential
Information  or file this Agreement if the Investor has  objected
to  such  disclosure or filing.  The Company will not, except  as
permitted  above,  file  this  Agreement  with  any  governmental
authority or any regulatory body, or disclose the identity of the
Investor or any other Confidential Information in any filing.

           (iv)  Announcement of Issuance.  At  any  time  within
sixty  (60) days after the Closing Date, the Company may issue  a
press  release announcing the existence of this Agreement,  which
press release will be in the form provided to the Company by  the
Investor.

          (v)  No Disclosure of Third Party Information.  Neither
party  will be required to disclose to the other any confidential
information of any third party without having first obtained such
third  party's prior written consent.  In any event, the  Company
shall   advise  the  Investor  of  the  fact  that  it  has   not
communicated  to  the Investor confidential  information  of  any
third  party  if  the Investor has requested information  of  the
nature  not disclosed or the failure to disclose such information
in  the  Disclosure Schedule would constitute  a  breach  of  any
representation or warranty in this Agreement.

<PAGE> 26

            (vi)  Other  Information.   The  provisions  of  this
Section  7(d)  shall be in addition to, and not  in  substitution
for,  the  provisions  of  any separate  nondisclosure  agreement
executed  by  any  of  the parties hereto  with  respect  to  the
transactions  contemplated  hereby.  Additional  disclosures  and
exchange of confidential information between the Company and  the
Investor  shall  be governed by the terms of the  Corporate  Non-
Disclosure  Agreement No. 3847738, dated June 28, 1999,  executed
by the Company and the Investor, and any Confidential Information
Transmittal Records provided in connection therewith.

     (e)  Rights of Participation.

           (i)   General.   Until  such  time  as  the  Investor,
together with its subsidiaries, no longer hold the equivalent  of
at  least  five percent (5%) of the outstanding voting securities
of  the  Company (such period from the date hereof  through  such
time  being  referred to herein as the "Initial Rights  Period"),
the Investor and each other person or entity to whom rights under
this  Section 7(e) have been duly assigned (each of the  Investor
and  each  such assignee, a "Participation Rights Holder")  shall
have  a  right  of  first refusal to purchase such  Participation
Rights  Holder's  Pro Rata Share (as defined below)  of  all  New
Securities (as defined below) that the Company may from  time  to
time  issue  during  such period (such New  Securities  would  be
allocated  among the Participation Rights Holders  who  elect  to
exercise  their right to purchase such New Securities  on  a  pro
rata  basis according to the number of Purchased Shares  held  by
each such Participation Rights Holder).  The rights described  in
the   preceding   sentence,   as  further   described   in   this
subsection  (e), are referred to as the "Right of Participation".
Notwithstanding  the  foregoing, a  Participation  Rights  Holder
shall  not  have the Right of Participation with respect  to  any
issuance of New Securities that would result in less than  a  ten
percent (10%) reduction in such Participation Rights Holder's Pro
Rata Share (where prior issuances of New Securities in which  the
such  Participation Rights Holder was not entitled to participate
are aggregated with the issuance in question for purposes of such
ten percent (10%) calculation).

           (ii)  Pro  Rata Share.  "Pro Rata Share"  means,  with
respect  to  each Participation Rights Holder, the ratio  of  the
following numbers calculated immediately prior to the issuance of
the  New  Securities giving rise to the Right  of  Participation:
(A)  the  Participant Share Number (as defined  below)  for  such
Participation  Rights  Holder,  to  (B)  the  difference  between
(1) the sum of (X) the total number of shares of Common Stock and
other voting capital stock of the Company then outstanding,  plus
(Y)  the  number of shares of voting capital stock issuable  upon
the exercise, conversion or exchange of any other security of the
Company   then  outstanding  and  (2)  the  number  of   Dilutive
Securities  issued  since  the last  Notice  Date  excluding  any
Maintenance  Securities issued pursuant to the  last  Maintenance
Notice.

           (iii)     New Securities.  "New Securities" means  any
Common  Stock, preferred stock or other voting capital  stock  or
security  of  the  Company, whether now authorized  or  not,  and
rights,  options  or warrants to purchase such  Common  Stock  or
preferred  stock or other voting capital stock or  security,  and
securities  of  any  type whatsoever that  are,  or  may  become,
convertible into or exchangeable or exercisable for Common Stock,
preferred  stock  or  other  voting capital  stock  or  security;
provided,  however,  that  the term "New  Securities"  shall  not
include:

<PAGE> 27

                (A)   any  shares of Common Stock (or options  or
warrants  therefor) issued to employees, officers,  directors  or
consultants  of  the Company pursuant to any  stock  purchase  or
stock option incentive plans approved by the Board;

                (B)  any securities issued as payment of fees  to
brokers, consultants or other advisors of the Company;

                (C)   the  Purchased  Shares  issued  under  this
Agreement;

                (D)  any securities issued in connection with any
stock  split, stock dividend or other similar event in which  all
Participation Rights Holders are entitled to participate on a pro
rata basis;

                (E)   any  securities issued upon  the  exercise,
conversion  or exchange of (1) the Debentures, (2) the  Warrants,
(3)   the  $3,000,000  in  principal  amount  of  5%  convertible
debentures  to  be  issued  pursuant to that  certain  Securities
Purchase  Agreement dated June 10, 1999 among the Company,  Brown
Simpson  Strategic Growth Fund, L.P. and Brown Simpson  Strategic
Growth  Fund, Ltd. (the "Brown Simpson Agreement"), (4)  warrants
to  purchase $3,000,000 of Common Stock to be issued pursuant  to
the  Brown  Simpson  Agreement, (5) any shares  of  Common  Stock
issued as payment of accrued interest on the securities listed in
(1),  (2), (3) or (4) above, or any outstanding security if  such
outstanding security constituted a New Security; or

                 (F)   any  securities  issued  pursuant  to  the
acquisition  of  another  person or  entity  by  the  Company  by
consolidation,   merger,   purchase   of   assets,    or    other
reorganization or, so long as such securities represent  no  more
than  five percent (5%) of the Company's voting securities  on  a
fully-diluted  basis,  issued in connection  with  the  Company's
participation in a joint venture or similar form of alliance.

           (iv)  Participant  Share Number.   "Participant  Share
Number",  with respect to a Participant Rights Holder, means  the
sum   of  (A)  the  number  of  Purchased  Shares  held  by  such
Participant  Rights  Holder, (B) the number of  shares  of  other
voting  capital stock or securities of the Company held  by  such
Participant Rights Holder, and (C) the number of shares of Common
Stock  or other voting capital stock or securities issuable  upon
the exercise, conversion or exchange of any other security of the
Company held by such Participant Rights Holder.

           (v)  Procedures.  If the Company proposes to undertake
an  issuance  of  New Securities (in a single  transaction  or  a
series of related transactions) in circumstances that entitled  a
Participation Rights Holder to participate therein in  accordance
with  this  subsection  (e),  the  Company  shall  give  to  each
Participation  Rights Holder written notice of its  intention  to
issue New Securities (the "Participation Notice"), describing the
amount  and  the  type of New Securities and the  price  and  the
general  terms upon which the Company proposes to issue such  New
Securities.  Each Participation Rights Holder shall have ten (10)
business  days from the date of receipt of any such Participation
Notice  to agree in writing to purchase up to the maximum  number
of  such New Securities that such Participation Rights Holder  is
entitled  to  purchase  for the price  and  upon  the  terms  and
conditions specified in the Participation Notice by

<PAGE> 28

giving  written  notice to the Company and  stating  therein  the
quantity  of  New Securities to be purchased (not to exceed  such
maximum).  If any Participation Rights Holder fails to  so  agree
in  writing  within  such  10  business  day  period,  then  such
Participation Rights Holder shall forfeit the right hereunder  to
participate  in  such sale of New Securities; provided,  however,
that  any  Participation  Rights Holders  that  have  elected  to
exercise  their  Right  of Participation  shall  be  entitled  to
exercise such right with respect to any New Securities where such
right  has  been  forfeited  by such other  Participation  Rights
Holder(s), and the Company shall repeat the procedures set  forth
in  this  paragraph  (e)(v)  to ascertain  whether  the  electing
Participation  Rights Holders desire to purchase such  other  New
Securities.    All   sales   hereunder   shall   be   consummated
concurrently  with the closing of the transaction triggering  the
Right of Participation.

           (vi) Failure to Exercise.  Upon the expiration of such
ten  (10) business day period, the Company shall have ninety (90)
days thereafter, subject to extensions for regulatory compliance,
to  sell the New Securities described in the Participation Notice
(with  respect to which the Participation Rights Holders'  rights
of first refusal hereunder were not exercised) at the price (or a
higher  price)  and  upon  non-price terms  not  materially  more
favorable  to  the  purchasers  thereof  than  specified  in  the
Participation  Notice.  If the Company has not  issued  and  sold
such  New Securities within such 90-day period, then the  Company
shall  not  thereafter issue or sell any New  Securities  without
again  first  offering such New Securities to  the  Participation
Rights Holders pursuant to this Section 7(e).

     (f)  Right of Maintenance.

           (i)  General.  Each Participation Rights Holder shall,
pursuant  to the terms and conditions of this Section 7(f),  have
the  right  to purchase from the Company Dilutive Securities  (as
defined  below)  ("Maintenance  Securities"),  as  a  result   of
issuances by the Company of Dilutive Securities that from time to
time  are issued after the Closing Date and before the expiration
of  the  Initial Rights Period, solely in order to maintain  such
Participation  Rights  Holder's  Prior  Percentage  Interest  (as
defined below) in the Company (the "Right of Maintenance").  Each
right  to  purchase  Maintenance  Securities  pursuant  to   this
Section 7(f) shall be on the same terms (other than price to  the
extent provided below) as the issuance of the Dilutive Securities
that  gave  rise  to  the  right  to  purchase  such  Maintenance
Securities.

           (ii) Dilutive Securities.  "Dilutive Securities" means
any  Common Stock, preferred stock or other voting capital  stock
or  security  (including, without limitation, any  Common  Stock,
voting  preferred stock or other voting capital stock or security
issued  upon  the exercise, conversion or exchange of  any  other
securities)  of  the  Company, whether  now  authorized  or  not;
provided, however, that the term "Dilutive Securities" shall  not
include:

                (A)   the  Purchased  Shares  issued  under  this
Agreement;

                (B)  any securities issued in connection with any
stock  split,  stock  dividend or  similar  event  in  which  all
Participation Rights Holders are entitled to participate on a pro
rata basis;

                (C)   any securities for which the issuance  gave
rise  to a Right of Participation (regardless of whether any such
right was exercised) or to a Corporate Event;

<PAGE> 29

                (D)   any  securities issuable upon the exercise,
conversion or exchange of any securities described in Clause  (C)
above;

                (E)   shares  of Common Stock issued  as  awards,
including  pursuant to exercise of options granted, to employees,
officers and directors under any plans approved by the Board; or

               (F)  shares of Common Stock issued upon conversion
of Debentures or upon exercise of Warrants.

            (iii)      Purchase  Price.   For  purposes  of  this
Section  7(f), the per share "Purchase Price" of the  Maintenance
Securities  shall equal the lower of (1) the sales price  of  the
Dilutive Securities and (2) the average Market Price (as  defined
below)  of such Maintenance Securities over the ten (10)  trading
days  immediately  preceding the date on which the  Participation
Rights Holder elects to purchase such Maintenance Securities.  If
the issuance of any Dilutive Securities occurs upon the exercise,
conversion   or   exchange  of  other  securities  ("Exchangeable
Securities"),  then  the per share price at which  such  Dilutive
Securities shall be deemed to have been issued shall be  the  sum
of  (x)  the per share amount paid upon such exercise, conversion
or  exchange, plus (y) the per share amount previously  paid  for
the Exchangeable Securities (adjusted for any stock splits, stock
dividends  or  other  similar  events).   For  purposes  of  this
Section  7(f)(iii), "Market Price" means, as to  any  Maintenance
Security  on  a given day, the average of the closing  prices  of
such  security's  sales  on  the  principal  domestic  securities
exchanges  on which such security may at the time be listed,  or,
if there have been no sales on any such exchange on such day, the
average  of the highest bid and lowest asked prices on  all  such
exchanges at the end of such day, or, if on any day such security
is not so listed, the average of the representative bid and asked
prices  quoted on Nasdaq as of 4:00 P.M., New York time, on  such
day, or, if on any day such security is not quoted on Nasdaq, the
average of the highest bid and lowest asked prices on such day in
the  domestic over-the-counter market as reported by the National
Quotation   Bureau,   Incorporated,  or  any  similar   successor
organization.   If  at any time a Maintenance  Security  are  not
listed on any domestic securities exchange or quoted on Nasdaq or
the domestic over-the-counter market ("Unlisted Securities"), the
"Market Price" shall be the fair value thereof determined jointly
by the Company and the Holder.

           (iv)  Alternative Purchase Price.  If a  Participation
Rights  Holder does not elect to purchase its Maintenance  Amount
(as  defined  below)  at  the time of issuance  of  any  Dilutive
Securities specified in a Maintenance Notice (as defined  below),
and in the written opinion of the Company's independent auditors,
made  available to each Participation Rights Holder upon request,
the  effect of determining the Purchase Price after such issuance
pursuant  to paragraph (iii) above would require the  Company  to
take a charge against earnings in accordance with GAAP, then  for
purposes  of this Section 7(f), "Purchase Price" shall  mean  the
Market  Price on the date the Participation Rights Holder  elects
to purchase its Maintenance Amount.

           (v)   Consideration  Other  than  Cash.   If  Dilutive
Securities   or   Exchangeable   Securities   were   issued   for
consideration  other than cash, the per share  amounts  paid  for
such  Dilutive  Securities or Exchangeable  Securities  shall  be
determined  jointly  in  good  faith  by  the  Company  and   the
Participation Rights Holder.

<PAGE> 30

           (vi)  Appraiser.  If the Company and the Participation
Rights  Holder are unable to reach agreement within a  reasonable
period  of time with respect to (A) the Market Price of  Unlisted
Securities  or  (B)  the  per  share amounts  paid  for  Dilutive
Securities  or  Exchangeable Securities issued for  consideration
other than cash, such Market Price or per share amounts paid,  as
the  case  may  be,  shall be determined by an appraiser  jointly
selected by the Company and the Participation Rights Holder.  The
determination of such appraiser shall be final and binding on the
Company  and  the  Participation Rights  Holder.   The  fees  and
expenses of such appraiser shall be paid by the Company.

           (vii)      Prior Percentage Interest.  A Participation
Rights  Holder's "Prior Percentage Interest" for purposes of  the
Right  of  Maintenance is the ratio of (A) the Participant  Share
Number  for  such Participation Rights Holder as of the  date  of
such   Maintenance  Notice  (the  "Notice  Date"),  to  (B)   the
difference between (1) the sum of (X) the total number of  shares
of  Common Stock and other voting capital stock and securities of
the  Company outstanding on the Notice Date, plus (Y) the  number
of shares of voting capital stock or securities issuable upon the
exercise,  conversion or exchange of any other  security  of  the
Company  outstanding as of such date (assuming, for  purposes  of
the  immediately preceding Clauses (X) and (Y), the Common  Stock
or  other  securities  described in such Maintenance  Notice  are
deemed  not  issued),  and  (2)  the  total  number  of  Dilutive
Securities  issued since the later of the Closing  Date  and  the
last Notice Date (but excluding any Maintenance Securities issued
pursuant to the last Maintenance Notice).

           (viii)    Maintenance Amount.  A Participation  Rights
Holder's  "Maintenance Amount" with respect  to  any  Maintenance
Notice shall equal such number of Maintenance Securities as shall
(upon  purchase  thereof  in  full by  the  Participation  Rights
Holder)  enable such Participation Rights Holder to maintain  its
Prior  Percentage  Interest  on a  fully-diluted  basis.   As  an
example,  assume  that the Company had 10,000 shares  outstanding
and  the Participation Rights Holder holds 20% of such shares (or
2,000  shares).  The Company first issues 400 shares to  a  third
party  ("Issuance 1"), an amount insufficient to trigger a Notice
of  Issuance  pursuant  to Section 7(f)(ix).   The  Company  then
proposes  to issue 4,600 shares to a third party ("Issuance  2"),
an  amount that triggers a Maintenance Notice.  The Participation
Rights  Holder shall have the right to maintain its 20%  interest
after considering Issuances 1 and 2 and the new shares issued  to
the   Participation   Rights  Holder.   In  this   example,   the
Participation Rights Holder shall have the right to  purchase  an
additional  1,250 shares, thereby resulting in the  Participation
Rights   Holder   holding  20%  of  the  securities   outstanding
(3,250 shares out of 16,250 shares).

          (ix) Maintenance Notice.  Within ten (10) business days
after each anniversary of the Closing Date, and at least ten (10)
business  days  before each issuance of Dilutive Securities  that
when  cumulated  with all prior issuances of Dilutive  Securities
since the later of (i) the Closing Date and (ii) the date of  the
last  Notice Date (which, as a result of which, the Participation
Rights   Holder  had  an  opportunity  to  purchase   Maintenance
Securities),  would  result in a five  percent  (5%)  or  greater
reduction  in  a  Participation Rights Holders' Prior  Percentage
Interest,  the  Company shall give to each  Participation  Rights
Holder  written notice (the "Maintenance Notice") describing  the
number of Dilutive Securities issued since such prior Notice Date
and  the price and non-price terms upon which the Company  issued
such Dilutive

<PAGE> 31

Securities,  and  the Maintenance Amount that such  Participation
Rights  Holder  is  entitled to purchase  as  a  result  of  such
issuances.

            (x)   Purchase  of  Maintenance  Securities.   If   a
Participation  Rights  Holder exercises  its  right  to  purchase
Dilutive Securities, such Participation Rights Holder shall  have
sixty  (60)  days  after the issuance of the Dilutive  Securities
specified  in  the applicable Maintenance Notice to purchase  its
Maintenance  Amount  at  the Purchase  Price  (as  determined  in
accordance with this Section 7(f)) and upon the other  terms  and
conditions  specified in the Maintenance Notice.  The closing  of
such  purchase  shall  occur within  ten  (10)  days  after  such
election  to purchase.  If any Participation Rights Holder  fails
to  elect  to  purchase such Participation Rights  Holder's  full
Maintenance  Amount of Maintenance Securities within such  60-day
period,  then such Participation Rights Holder shall forfeit  the
right  hereunder to purchase that part of its Maintenance  Amount
that it did not so elect to purchase.

          (xi) Termination.  The Company's obligations under this
Section  7(f)  shall  terminate  upon  the  earlier  of  (A)  the
expiration of the Initial Rights Period and (B) the date which is
the fifth (5th) anniversary of the Closing Date.

     (g)  Rights Relating to a Corporate Event.

           (1)  Corporate Events.  A "Corporate Event" shall mean
any  of  the  following, whether accomplished through  one  or  a
series of related transactions:  (A) any transaction, other  than
an  issuance of securities in connection with the acquisition  of
an  unaffiliated third party in an arms length transaction,  that
results  in  a  greater than thirty percent (30%) change  in  the
total  outstanding  number  of  voting  securities  (which,   for
purposes  of  this  Agreement, shall mean all securities  of  the
Company that presently are, or would be upon conversion, exchange
or  exercise,  entitled to vote in the election of directors)  of
the  Company immediately prior to such issuance (other  than  any
such  change solely as a result of a stock split, stock  dividend
or  other recapitalization affecting holders of Common Stock  and
other  classes of voting securities of the Company on a pro  rata
basis);  (B)  an  acquisition  of  the  Company  or  any  of  its
"significant subsidiaries" (as defined in the SEC's Rule  1-02(w)
of Regulation S-X) ("Significant Subsidiaries") by consolidation,
merger (regardless of whether the Company is the survivor of such
merger   or   not),   share  purchase  or   exchange   or   other
reorganization  or  transaction  in  which  the  holders  of  the
Company's  or  such  Significant Subsidiary's outstanding  voting
securities immediately prior to such transaction own, immediately
after  such transaction, securities representing less than  fifty
percent  (50%)  of  the  voting power of the  Company,  any  such
Significant  Subsidiary or the Person issuing such securities  or
surviving  such  transaction,  as  the  case  may  be;  (C)   the
acquisition of all or substantially all the assets of the Company
or  any  Significant Subsidiary; (D) the grant by the Company  or
any  of its Significant Subsidiaries of an exclusive license  for
any  material  portion  of  the  Company's  or  such  Significant
Subsidiary's  Intellectual Property to a Person  other  than  the
Investor  or any of its subsidiaries; and (E) any transaction  or
series of related transactions that results in the failure of the
majority  of  the members of the Board immediately prior  to  the
closing  of  such  transaction or series of related  transactions
failing  to constitute a majority of the Board (or its successor)
immediately  following  such transaction  or  series  of  related
transactions.

<PAGE> 32

           (2)  Notice of Corporate Events.  Until expiration  of
the  Notification  Period (as defined below), the  Company  shall
provide the Investor with detailed written notice of terms of any
offer  (written or oral) from any person or entity for a proposed
Corporate  Event.  Any notice shall be delivered to the  Investor
as  soon  as practicable but no later than two (2) business  days
after  the date the Company first becomes aware of such offer  or
proposed Corporate Event.  Without limiting the generality of the
foregoing, such notice shall set forth the identity(ies)  of  the
person(s) or entity(ies) involved, the consideration to  be  paid
and all other material terms and conditions.  If such offer is in
writing (whether in the form of a letter of intent, term sheet or
otherwise),  the  Company shall deliver a  copy  thereof  to  the
Investor.

           (3)   Right  of  First  Refusal.   During  the  period
commencing  on the Closing Date and ending on the date  which  is
six (6) months thereafter (the "ROFR Period"), the Company shall,
prior  to  effecting  or  entering into  any  agreement  for  any
Corporate  Event,  present to the Investor in writing  the  final
terms  and  conditions of the proposed Corporate Event, including
the name of the other party or parties to the Corporate Event and
a  copy of the definitive agreements that the Company is prepared
to   enter  into  (such  information  and  agreements,  a  "Final
Notice").   The Investor shall have ten (10) business days  after
the date of receipt of the Final Notice to deliver written notice
to  the  Company agreeing to enter into a written agreement  with
the  Company  on  substantially the  same  terms  and  conditions
specified in the Final Notice, which agreement shall nevertheless
provide  for  consummation of the transaction within one  hundred
twenty  (120) days after the date of delivery of the Final Notice
(such  120  day  period  subject  to  extensions  for  regulatory
compliance).  During such (10) business day period, the  Investor
shall  be  entitled to conduct due diligence with the  reasonable
cooperation of the Company.  If the Investor fails to enter  into
a  definitive agreement within such 10 business day period, for a
period of ninety (90) days thereafter, the Company shall have the
right  to enter into an agreement regarding such Corporate  Event
with  the  party  or  parties specified in the  applicable  Final
Notice;  provided,  however, that such  definitive  agreement  is
entered  into  within ninety (90) days following  termination  of
such  ten  (10)  business day period; provided further,  that  if
during such ten (10) business day period, the Investor shall have
made  a  written  offer for the acquisition of the  Company,  the
Corporate  Event with such a third party shall be  for  at  least
ninety-five  (95%) of the price offered by the  Investor  and  on
other terms no less favorable to shareholders of the Company than
the  terms of the offer proposed by the Investor with respect  to
shareholders other than the Investor.

           (4)   Right of Resale.  If the Investor shall fail  to
exercise  its  right  of first refusal as to  a  Corporate  Event
pursuant  to  Section  7(g)(3),  the  Investor  shall,  upon  the
Company's  entering into an agreement to consummate  a  Corporate
Event, have the right to sell to the Company any or all shares of
Purchased   Shares  and  all  New  Securities   and   Maintenance
Securities then owned by the Investor.  Such sale shall  be  made
on the following terms and conditions:

                (A)  The price per share at which such shares are
to  be sold to Company shall be equal to the greater of:  (1) the
Per  Share  Purchase Price and (2) either the highest  price  per
share  of  capital stock (or equivalent) paid in connection  with
the Corporate Event or, if the transaction involves the sale of a
Significant Subsidiary or assets or the licensing of Intellectual
Property,  the  Investor's pro rata share  of  the  consideration
received, directly or

<PAGE> 33

indirectly, by the Company in such transaction based on its  then
fully-diluted ownership of the Company's capital stock.

                (B)  The Company shall reimburse the Investor for
any and all fees and expenses, including legal fees and expenses,
incurred in connection with this Section 7(g)(4).

                (C)   Within  fifteen  (15)  days  prior  to  the
consummation  of the Corporate Event, the Investor shall  deliver
to  the  Company  the  certificate or  certificates  representing
shares  to be sold, each certificate to be properly endorsed  for
transfer.

                (D)   The  Company  shall,  concurrent  with  the
closing of the Corporate Event, pay the aggregate purchase  price
therefor  and  the amount of reimbursable fees  and  expenses  as
specified in Section 7(g)(4)(B) in cash.

           (5)  Right of Notification and First Negotiation.  For
a  period  (X) commencing upon expiration of the ROFR Period  and
(Y)  ending on the day that is nine hundred (900) days after such
last day (the "Notification Period"), the Company shall, prior to
the  Board's approving or disapproving a Corporate Event  or  the
Company's  or any of its subsidiaries' entering into a definitive
agreement with respect to a Corporate Event, notify the  Investor
of  all  terms  and conditions of such Corporate Event  and  then
attempt to negotiate in good faith with the Investor for a period
of  not  less  than ten (10) business days for  the  Investor  to
acquire  the  Company  (or a Significant  Subsidiary,  assets  or
license,  as  the  case may be) or enter into  another  Corporate
Event  with  the  Company.  During such  ten  (10)  business  day
period,  the Investor shall be entitled to conduct due  diligence
with the reasonable cooperation of the Company.  During such  ten
(10)  business day period, any alternative proposal made  by  the
Investor shall be submitted by the Company to the Board  and  the
Board  shall,  in  good faith, either approve or  disapprove  the
Investor's alternative proposal.  To the extent that the  Company
and  the Investor do not enter into an agreement with respect  to
such  an  acquisition or other Corporate Event with the  Investor
during such ten (10) business day period, the Board shall be free
to  approve  or disapprove such Corporate Event and  the  Company
shall  be free to enter into a definitive agreement with  respect
to  a  Corporate  Event  with  a  third  party  and  subsequently
consummate such Corporate Event.

            (6)   Notice  of  Ten  Percent  Acquisitions.   Until
expiration  of  the  Initial  Rights Period,  the  Company  shall
provide  the Investor with detailed written notice of the earlier
of  the following events: (X) the Company's first becoming  aware
of  any  person  or entity acquiring after the  date  hereof  any
outstanding voting securities of the Company such that  following
such acquisition such person or entity owns ten percent (10%)  or
more  of the Company's outstanding voting securities, or (Y)  the
terms  of any offer or proposal (written or oral) after the  date
hereof  from  any  person  or  entity  such  that  following  the
consummation of any such offer or proposal such person or  entity
would  own ten percent (10%) or more of the Company's outstanding
voting securities.  Any notice shall be delivered to the Investor
within  three (3) business days after the date the Company  first
becomes  aware  of  such acquisition, offer  or  proposal.   Such
notice  shall  set  forth, to the extent known  by  Company,  the
identity(ies)  of  the  person(s) or  entity(ies)  involved,  the
consideration paid or to be paid and all other material terms

<PAGE> 34

and conditions.  If such offer or proposal is in writing (whether
in  the form of a letter of intent, term sheet or otherwise), the
Company shall deliver a copy thereof to the Investor.

8.   INDEMNIFICATION.

     (a)  Agreement to Indemnify.

           (i)   Company Indemnity.  The Investor, its Affiliates
and   Associates,   and  each  officer,  director,   shareholder,
employer,  representative  and agent  of  any  of  the  foregoing
(collectively,  the  "Investor  Indemnitees")   shall   each   be
indemnified  and held harmless to the extent set  forth  in  this
Section 8 by the Company with respect to any and all Damages  (as
defined below) incurred by any Investor Indemnitee as a proximate
result  of any inaccuracy or misrepresentation in, or breach  of,
any  representation, warranty, covenant or agreement made by  the
Company  in this Agreement (including any exhibits and  schedules
hereto).  Indemnification claims arising from the registration of
Purchased  Shares  under Federal and state  securities  laws  are
covered by Section 7(c) and not this Section 8.

           (ii)  Investor Indemnity.  The Company, its respective
Affiliates   and   Associates,  and   each   officer,   director,
shareholder,  employer, representative and agent of  any  of  the
foregoing (collectively, the "Company Indemnitees") shall each be
indemnified  and held harmless to the extent set  forth  in  this
Section  8,  by the Investor, in respect of any and  all  Damages
incurred by any Company Indemnitee as a proximate result  of  any
inaccuracy   or   misrepresentation  in,  or   breach   of,   any
representation,  warranty, covenant  or  agreement  made  by  the
Investor in this Agreement.  Indemnification claims arising  from
the  registration  of Purchased Shares under  Federal  and  state
securities  laws  are  covered  by  Section  7(c)  and  not  this
Section 8.

           (iii)     Equitable Relief.  Nothing set forth in this
Section  8  shall  be  deemed to prohibit or limit  any  Investor
Indemnitee's or Company Indemnitee's right at any time before, on
or  after  the  Closing, to seek injunctive  or  other  equitable
relief  for  the failure of any Indemnifying Party to perform  or
comply with any covenant or agreement contained herein.

      (b)   Survival.  All representations and warranties of  the
Investor and the Company contained herein and all claims  of  any
Investor  Indemnitee  or Company Indemnitee  in  respect  of  any
inaccuracy  or  misrepresentation  in  or  breach  hereof,  shall
survive  the Closing until the second anniversary of the date  of
this  Agreement, regardless of whether the applicable statute  of
limitations,  including  extensions  thereof,  may  expire.   All
covenants  and  agreements  of  the  Investor  and  the   Company
contained  in  this  Agreement  shall  survive  the  Closing   in
perpetuity  (except to the extent any such covenant or  agreement
shall   expire  by  its  terms).   All  claims  of  any  Investor
Indemnitee or Company Indemnitee in respect of any breach of such
covenants  or  agreements shall survive  the  Closing  until  the
expiration  of  one  year  following  the  non-breaching  party's
obtaining actual knowledge of such breach.

     (c)  Claims for Indemnification.  If any Investor Indemnitee
or  Company Indemnitee (an "Indemnitee") shall believe that  such
Indemnitee  is  entitled  to  indemnification  pursuant  to  this
Section  8 in respect of any Damages, such Indemnitee shall  give
the appropriate Indemnifying Party (which for purposes hereof, in
the case of an Investor Indemnitee, means the

<PAGE> 35

Company,  and  in  the  case of a Company Indemnitee,  means  the
Investor)  prompt written notice thereof.  Any such notice  shall
set  forth in reasonable detail and to the extent then known  the
basis  for such claim for indemnification.  The failure  of  such
Indemnitee  to  give  notice  of any  claim  for  indemnification
promptly  shall not adversely affect such Indemnitee's  right  to
indemnity  hereunder  except  to the  extent  that  such  failure
adversely  affects the right of the Indemnifying Party to  assert
any  reasonable  defense  to such claim.   Each  such  claim  for
indemnity shall expressly state that the Indemnifying Party shall
have only the twenty (20) business day period referred to in  the
next  sentence  to dispute or deny such claim.  The  Indemnifying
Party  shall have twenty (20) business days following its receipt
of  such  notice either (i) to acquiesce in such claim by  giving
such  Indemnitee written notice of such acquiescence or  (ii)  to
object  to the claim by giving such Indemnitee written notice  of
the objection.  If the Indemnifying Party does not object thereto
within  such  twenty  (20) business day period,  such  Indemnitee
shall  be  entitled to be indemnified for all Damages  reasonably
and  proximately incurred by such Indemnitee in respect  of  such
claim.   If  the Indemnifying Party objects to such  claim  in  a
timely  manner,  the  senior management of the  Company  and  the
Investor shall meet to attempt to resolve such dispute.   If  the
dispute cannot be resolved by the senior management, either party
may  make  a  written  demand for formal dispute  resolution  and
specify  therein  the scope of the dispute.  Within  thirty  (30)
days  after such written notification, the parties agree to  meet
for  one  (1) day with an impartial mediator and consider dispute
resolution alternatives other than litigation.  If an alternative
method  of  dispute resolution is not agreed upon  within  thirty
days  after  the  one  day  mediation,  either  party  may  begin
litigation proceedings.  Nothing in this section shall be  deemed
to require arbitration.

      (d)   Defense of Claims.  In connection with any claim that
may give rise to indemnity under this Section 8 resulting from or
arising out of any claim or Proceeding against an Indemnitee by a
person  or  entity  that is not a party hereto, the  Indemnifying
Party  may  (unless such Indemnitee elects not to seek  indemnity
hereunder  for  such claim) but shall not be obligated  to,  upon
written notice to the relevant Indemnitee, assume the defense  of
any  such  claim  or  Proceeding if the Indemnifying  Party  with
respect  to  such  claim  or  Proceeding  acknowledges   to   the
Indemnitee the Indemnitee's right to indemnity pursuant hereto to
the  extent provided herein (as such claim may have been modified
through   written   agreement  of  the  parties)   and   provides
assurances, reasonably satisfactory to such Indemnitee, that  the
Indemnifying Party will be financially able to satisfy such claim
to  the  extent  provided herein if such claim or  Proceeding  is
decided  adversely;  provided, however, that  nothing  set  forth
herein shall be deemed to require the Indemnifying Party to waive
any  crossclaims or counterclaims the Indemnifying Party may have
against the Indemnified Party for damages.  The Indemnified Party
shall   be   entitled  to  retain  separate  counsel,  reasonably
acceptable  to  the Indemnifying Party, if the Indemnified  Party
shall  determine,  upon the written advice of  counsel,  that  an
actual  or  potential  conflict of interest  exists  between  the
Indemnifying  Party and the Indemnified Party in connection  with
such  Proceeding.  The Indemnifying Party shall be  obligated  to
pay the reasonable fees and expenses of such separate counsel  to
the  extent  the Indemnified Party is entitled to indemnification
by   the  Indemnifying  Party  with  respect  to  such  claim  or
Proceeding  under  this Section 8(d).  If the Indemnifying  Party
assumes  the  defense  of  any  such  claim  or  Proceeding,  the
Indemnifying Party shall select counsel reasonably acceptable  to
such  Indemnitee  to  conduct  the  defense  of  such  claim   or
Proceeding,  shall  take all steps necessary in  the  defense  or
settlement thereof and shall at all times diligently and promptly
pursue  the resolution thereof.  If the Indemnifying Party  shall
have assumed the defense of any claim or Proceeding in accordance

<PAGE> 36

with   this  Section  8(d),  the  Indemnifying  Party  shall   be
authorized  to consent to a settlement of, or the  entry  of  any
judgment  arising  from, any such claim or Proceeding,  with  the
prior  written consent of such Indemnitee, not to be unreasonably
withheld;  provided, however, that the Indemnifying  Party  shall
pay  or  cause  to  be  paid  all amounts  arising  out  of  such
settlement   or  judgment  concurrently  with  the  effectiveness
thereof; provided further, that the Indemnifying Party shall  not
be  authorized to encumber any of the assets of any Indemnitee or
to agree to any restriction that would apply to any Indemnitee or
to  its  conduct  of  business;  and  provided  further,  that  a
condition  to any such settlement shall be a complete release  of
such   Indemnitee   and  its  Affiliates,  directors,   officers,
employees  and  agents with respect to such claim, including  any
reasonably  foreseeable  collateral consequences  thereof.   Such
Indemnitee shall be entitled to participate in (but not  control)
the  defense of any such action, with its own counsel and at  its
own  expense.  Each Indemnitee shall, and shall cause each of its
Affiliates,  directors,  officers,  employees  and   agents   to,
cooperate fully with the Indemnifying Party in the defense of any
claim  or  Proceeding  being defended by the  Indemnifying  Party
pursuant  to this Section 8(d).  If the Indemnifying  Party  does
not  assume  the  defense  of any claim or  Proceeding  resulting
therefrom in accordance with the terms of this Section 8(d), such
Indemnitee  may defend against such claim or Proceeding  in  such
manner as it may deem appropriate, including settling such  claim
or Proceeding after giving notice of the same to the Indemnifying
Party, on such terms as such Indemnitee may deem appropriate.  If
any Indemnifying Party seeks to question the manner in which such
Indemnitee defended such claim or Proceeding or the amount of  or
nature of any such settlement, such Indemnifying Party shall have
the  burden to prove by a preponderance of the evidence that such
Indemnitee  did  not  defend  such  claim  or  Proceeding  in   a
reasonably prudent manner.

      (e)   Certain  Definitions. As  used  in  this  Section  8,
(a)  "Affiliate" means, with respect to any person or entity, any
person  or  entity directly or indirectly controlling, controlled
by  or  under direct or indirect common control with  such  other
person or entity; (b) "Associate" means, when used to indicate  a
relationship with any person or entity, (1) any other  person  or
entity  of  which  such  first person or entity  is  an  officer,
director or partner or is, directly or indirectly, the beneficial
owner  of  ten  percent  (10%) or more of  any  class  of  equity
securities,  membership interests or other  comparable  ownership
interests issued by such other person or entity, (2) any trust or
other  estate  in  which such first person or entity  has  a  ten
percent  (10%)  or more beneficial interest or as to  which  such
first  person  or  entity  serves as  trustee  or  in  a  similar
fiduciary capacity, and (3) any relative or spouse of such  first
person  or  entity who has the same home as such first person  or
entity  or  who is a director or officer of such first person  or
entity;  (c)  "Damages"  means all demands,  claims,  actions  or
causes  of action, assessments, losses, damages, costs, expenses,
liabilities, judgments, awards, fines, response costs, sanctions,
taxes,   penalties,  charges  and  amounts  paid  in  settlement,
including (1) interest on cash disbursements in respect of any of
the  foregoing at the prime rate of Chase Manhattan Bank,  as  in
effect  from  time to time, compounded quarterly, from  the  date
each  such  cash  disbursement is made until the date  the  party
incurring  such cash disbursement shall have been indemnified  in
respect thereof, and (2) reasonable out-of-pocket costs, fees and
expenses  (including  reasonable  costs,  fees  and  expenses  of
attorneys,  accountants and other agents  of,  or  other  parties
retained by, such party), and (d) "Proceeding" means any  action,
suit, hearing, arbitration, audit, proceeding (public or private)
or  investigation that is brought or initiated by or against  any
federal,  state, local or foreign governmental authority  or  any
other person or entity.

<PAGE> 37

9.   ASSIGNMENT.  The rights of the Investor under Sections 7(b),
(c), (e) and (f) are transferable only to a person or entity  who
acquires  at  least twenty percent (20%) of the Purchased  Shares
issued on the Closing Date (subject to appropriate adjustment for
all  stock splits, dividends, combinations, recapitalizations and
the  like where all holders of Common Stock participate on a  pro
rata  basis); provided, however, that no person or entity may  be
assigned any of the foregoing rights unless the Company is  given
written  notice  by  the assigning party  at  the  time  of  such
assignment  stating  the name and address  of  the  assignee  and
identifying the securities of the Company as to which the  rights
in  question are being assigned; and provided further,  that  any
such  assignee shall receive such assigned rights subject to  all
the  terms and conditions of this Agreement (including all  terms
and  conditions governing the duration and termination of  rights
of  the Investor).  The rights of the Investor under Section 7(g)
may  be  assigned  only  to  one of its  subsidiaries;  provided,
however,   that   no  such  assignment  of  such   rights   under
Section  7(g)  shall  be effective until  the  Company  is  given
written  notice by the Investor stating the name and  address  of
the  assignee; and provided further, that any such assignee shall
receive  such  assigned  rights subject  to  all  the  terms  and
conditions of this Agreement.

10.  MISCELLANEOUS.

      (a)   Successors and Assigns.  The terms and conditions  of
this  Agreement will inure to the benefit of and be binding  upon
the respective successors and assigns of the parties.

      (b)  Governing Law.  This Agreement will be governed by and
construed  under  the  internal laws of the  State  of  Delaware,
without reference to principles of conflict of laws or choice  of
laws.

     (c)  Counterparts.  This Agreement may be executed in two or
more counterparts, each of which will be deemed an original,  but
all   of  which  together  will  constitute  one  and  the   same
instrument.

      (d)   Headings.   The headings and captions  used  in  this
Agreement  are  used  for convenience only  and  are  not  to  be
considered in construing or interpreting this Agreement.

      (e)   Notices.  Any notice required or permitted under this
Agreement  shall  be given in writing, shall  be  effective  when
received,  and  shall  in  any  event  be  deemed  received   and
effectively  given  upon personal delivery to  the  party  to  be
notified or three (3) business days after deposit with the United
States  Post  Office,  by registered or certified  mail,  postage
prepaid,  or one (1) business day after deposit with a nationally
recognized  courier service such as FedEx for next  business  day
delivery  under  circumstances in which such  service  guarantees
next  business  day  delivery, or  one  (1)  business  day  after
facsimile with copy delivered by registered or certified mail, in
any  case,  postage  prepaid and addressed to  the  party  to  be
notified at the address indicated for such party on the signature
page  hereof  or  at such other address as the  Investor  or  the
Company  may  designate by giving at least ten (10) days  advance
written notice pursuant to this Section 10(e).

      (f)  Amendments and Waivers.  This Agreement may be amended
and  the  observance of any term of this Agreement may be  waived
(either generally or in a particular

<PAGE> 38

instance  and either retroactively or prospectively),  only  with
the  written consent of the Company and the holders of  Purchased
Shares  (together with all New Securities purchased  pursuant  to
Section 7(e) and all Maintenance Shares) representing at least  a
majority  of  the  total  aggregate number  of  Purchased  Shares
(together   with  all  New  Securities  purchased   pursuant   to
Section   7(e)  and  all  Maintenance  Shares)  then  outstanding
(excluding  any  of  such  shares  that  have  been  sold  in   a
transaction  in which rights under Section 7(c) are not  assigned
in  accordance with this Agreement or sold to the public pursuant
to  SEC Rule 144 or otherwise).  Any amendment or waiver effected
in  accordance with this Section 10(g) will be binding  upon  the
Investor,  the  Company  and  their  respective  successors   and
assigns.   Notwithstanding  the  foregoing,  the  provisions   of
subsections (c), (d), (e), (f) and (g) of Section 7, and  all  of
Section 8, may not be amended without the written consent of  the
Company  and  the Investor, which may be withheld  in  either  of
their sole and absolute discretions.

      (g)   Severability.  If any provision of this Agreement  is
held  to  be  unenforceable under applicable law, such  provision
will  be  excluded  from this Agreement and the  balance  of  the
Agreement  will  be  interpreted as if  such  provision  were  so
excluded and will be enforceable in accordance with its terms.

     (h)  Entire Agreement.  This Agreement, and all exhibits and
schedules  hereto (including the Disclosure Schedule), which  are
hereby  incorporated by reference into and made an integral  part
of   this   Agreement,  constitutes  the  entire  agreement   and
understanding  of the parties with respect to the subject  matter
hereof   and   supersedes   any  and  all   prior   negotiations,
correspondence, agreements, understandings duties or  obligations
between the parties with respect to the subject matter hereof.

      (i)   Further Assurances.  From and after the date of  this
Agreement  upon the request of the Company or the  Investor,  the
Company   and   the  Investor  will  execute  and  deliver   such
instruments,  documents or other writings, and  take  such  other
actions,  as may be reasonably necessary or desirable to  confirm
and carry out and to effectuate fully the intent and purposes  of
this Agreement.

      (j)   Meaning of Include and Including; Article and Section
References.   Whenever in this Agreement the  word  "include"  or
"including" is used, it shall be deemed to mean "include, without
limitation" or "including, without limitation," as the  case  may
be, and the language following "include" or "including" shall not
be  deemed  to  set  forth an exhaustive  list.   All  "Article",
"Section",  "subsection",  "paragraph"  and  "Clause"  references
herein   are   references  to  Articles,  Sections,  subsections,
paragraphs  and  clauses, respectively, of this Agreement  unless
otherwise specified.

      (k)   Fees,  Costs  and  Expenses. Except  as  contemplated
otherwise   by  Section  5(h),  all  fees,  costs  and   expenses
(including attorney's' fees and expenses) incurred by either part
hereto  in  connection  with  the  preparation,  negotiation  and
execution  of  this  Agreement  and  the  consummation   of   the
transactions contemplated hereby and thereby (including the costs
associated with any filings with, or compliance with any  of  the
requirements of, any governmental authorities), shall be the sole
and exclusive responsibility of such party.

<PAGE> 39

      (l)  Competition.  Nothing set forth herein shall be deemed
to  preclude,  limit or restrict the Company's or the  Investor's
ability to compete with the other.

      (m)  Stock Splits, Dividends and other Similar Events.  The
provisions of this Agreement (including the number of  shares  of
Common   Stock  (including  the  Purchased  Shares)   and   other
securities  described herein) shall be appropriately adjusted  to
reflect any stock split, stock dividend, reorganization or  other
similar  event  that may occur with respect to the Company  after
the date hereof.

     [The balance of this page is intentionally left blank.]

<PAGE> 40

IN  WITNESS  WHEREOF,  the  parties  hereto  have  executed  this
Agreement as of the date and year first above written.

ESOFT, INC.                      INTEL CORPORATION

By:  /s/Jeff Finn                By:  /s/Arvind Sodhani
     -----------------------          -------------------------
Name:   Jeff Finn                Name:   Arvind Sodhani
Title:  CEO                      Title:  Vice President and
                                         Treasurer

Date Signed:  11/12/99           Date Signed:  12 November 1999

Address:                         Address:
295 Interlocken Blvd., #500      2200 Mission College Road
Broomfield, Colorado  80021      Santa Clara, California  95052
Telephone No: (303) 444-1600     Telephone No.: (408) 765-8080
Facsimile No: (303) 444-1640     Facsimile No.: (408) 765-6038

with copies to:                  with copies to:
Davis, Graham & Stubbs LLP       Intel Corporation
Attention: Lester R. Woodward    Attention:  M&A Portfolio Mgr.
Suite 4700                       2200 Mission College Road
3700 17th Street                 Santa Clara, California  95052
Denver, Colorado  80201
Telephone No.: (303) 892-7392    and
Facsimile No.: (303) 893-1379    Gibson, Dunn & Crutcher LLP
                                 Attention: Gregory J. Conklin
                                 One Montgomery Street
                                 Telesis Tower
                                 San Francisco, California 94104
                                 Telephone No.: (415) 393-8200
                                 Facsimile No.: (415) 986-5309


 {Signature page to Stock Purchase and Investor Rights Agreement
           between Intel Corporation and eSoft, Inc.}








© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission